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Abstract 
Research undertaken in the last three decades has consistently reported that the length 
of time spent in inpatient and outpatient alcohol and other drug (AOD) treatment 
programs predicts treatment success (De Leon, Melnick, Kressel, & Jainchill, 1994; 
Hubbard, Craddock, & Anderson, 2003; Simpson, Joe, Fletcher, Hubbard, & Anglin, 
1999). However, treatment attrition rates are high and present a major problem for 
improving treatment outcomes. Various factors that have been reportedly associated 
with increased AOD treatment attrition rates include being female, younger clients, 
clients using methamphetamines, and clients with elevated psychopathology scores. 
The aim of this thesis is to improve understanding of various factors reported in the 
research literature to influence AOD treatment retention, including client 
psychopathology, age, gender and primary drug of abuse. 
The research was conducted in two phases.  Phase one involved an analysis of 
archival data of clients admitted to a single Australian therapeutic community (TC) 
program over a 6-year period (2000-2005).The second stage involved a focus group 
comprised of nine Australian and New Zealand therapeutic community managers and 
senior clinicians who discussed the findings from the first phase of the study and 
provided feedback on these findings. The focus group also discussed barriers and 
solutions to incorporating these findings in TC treatment services. The results from 
the first phase indicated that elevated anxiety and depression scores at entry to 
treatment were strong predictors of client retention at 8 weeks, and retention at 14 
weeks was predicted by high self-esteem scores at entry. Clients receiving medication 
(primarily anti-depressant medication) were more likely retained at 14 weeks. Older 
clients (24 – 29 years, and 30 – 50 years) were significantly more likely to drop out of 
treatment by the 14 week stage compared with the younger client group (17 – 24 
years).  
The second stage revealed general agreement with the findings, provided 
support for the efficacy of TC treatment for clients with comorbid mental health 
problems, highlighted challenges and benefits of working with mental health services, 
and suggested other factors influencing treatment retention. The first stage findings 
contribute to the understanding of TC treatment retention factors with an Australian 
population, but do not support previous findings that female clients, younger clients, 
clients with elevated anxiety or depression scores, or clients with methamphetamine 
abuse problems are more likely to drop out of TC treatment.  
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This study involved the collection of a large client database from a single TC 
over six years, including the longitudinal collection of client psychometric data at 
various stages throughout treatment. This study makes an important contribution to 
the understanding of various client factors and their respective influence on client 
retention and attrition within an Australian therapeutic community. The study has 
relevance for residential substance abuse treatment services in many countries, but has 
special relevance within Australia where few studies focusing on TC retention have 
been undertaken. There have been even less studies focusing on TC retention that 
have included longitudinal psychometric data collected from a client population 
primarily comprised of young methamphetamine-users. 
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Introduction 
 
Significance of This Study 
Substance abuse continues to be a major social, health and economic problem 
in many countries. Scott, Dennis, Laudet, Funk, and Simeone (2011) report U.S. 
research indicating that individuals with a drug dependence diagnosis on average die 
22.5 years earlier than those without such a diagnosis. The authors also report the 
finding that 2.8 % of the U.S. population (6.9 million persons) currently meet the 
diagnostic criteria for substance abuse disorders (Scott, et al., 2011, p. 737).  
Increasing the effectiveness of substance abuse treatment is consequently an 
important health and economic goal for many nations. Substance abuse treatment 
programs can be divided into outpatient and inpatient programs, and inpatient 
programs are commonly called residential programs. Residential programs are 
typically regarded as more expensive to operate than outpatient programs; however 
they remain a common form of substance abuse treatment, especially for persons with 
more severe substance abuse problems. Therapeutic communities are a particular 
form of residential substance abuse treatment that are usually structured in a 
hierarchical manner with residents expected to take increasing responsibility within 
the community as they progress with their recovery. Therapeutic communities are 
often utilised by  persons who have a history of substance abuse treatment failure, 
more severe substance abuse problems, unstable living conditions, involvement with 
criminal activity, and injecting drug users (De Leon, 2000). The effectiveness of 
many forms of substance abuse treatment is predicted by the length of time in 
treatment, and yet premature treatment attrition remains common, especially from 
residential treatment programs, including TCs. Although the typical duration of client 
stay in TC treatment programs during the 1960’s and 1970’s was 2-3 years, it is now 
common for TC programs to be only 3, 6 or 12 months long (De Leon, 2000, p.3). 
Attrition from these modern shorter TC programs remains a major barrier however for 
the provision of effective treatment. Obtaining a better understanding of the factors 
that predict client retention and attrition from TCs has therefore been the focus of 
much published substance abuse treatment research in recent decades.  
Previous studies examining factors that contribute to treatment retention in 
therapeutic communities for people with substance abuse problems have almost 
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always been conducted in the United States and Western Europe. There have been 
very few published studies examining treatment retention in Australian TCs. A 
comparison of US and Australian national household studies of substance abuse notes 
many significant differences in the patterns of substance abuse between these two 
countries (Maxwell, 2008). The author notes many significant differences between 
Australia and US prevalence rates of life-time use of various types of substances, and 
states that since 1998 substance use within Australia has decreased significantly for 
most drugs (excluding alcohol and ecstasy), however use of most illicit drugs in the 
US has increased. As substance abuse patterns and populations can differ significantly 
between countries, it is important to better understand treatment retention factors in 
Australian TC’s, because there may be significantly different patterns of substance 
abuse and cultural norms that may influence treatment retention and attrition. 
Within a particular country there may also be significant differences between 
patterns of substance abuse and the profile of the treatment population. An example of 
this within-country difference is that during the period of this data collection there 
was a greater proportion of the AOD treatment population presenting with 
methamphetamine problems in Western Australia compared to eastern states 
(Australian Institute of Health and Welfare, 2006). It is therefore probable that these 
within-country differences in population substance-using profile will be reflected in 
differing treatment retention rates due to the influence of factors believed to influence 
client treatment retention (e.g. primary drug of abuse and mental health difficulties). 
Another potentially confounding factor of adopting findings from various TC 
retention studies is there is often significant variation between these programs, 
including beliefs about addiction and substance abuse recovery. These differences 
may manifest as differences in therapeutic content, therapeutic emphasis, program 
structure, staffing structure, and support services. These program differences are 
sometimes termed program factors, and it is increasingly common to include or note 
these factors in recent studies of client treatment retention (Curran, Stecker, Han, & 
Booth, 2007). The significant program structure and staffing variations between some 
TC’s mean that these program factor differences may have a confounding influence 
on retention findings. The relevance of some TC program factors to client retention 
and attrition is explored and discussed in the second stage of this thesis. 
The present study is, therefore, a very useful addition to the knowledge base of 
client retention and attrition from Australian TCs because it contains a large sample of 
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client data obtained from one Western Australian TC program that maintained 
continuity of most of the various differential program factors mentioned above during 
the 6-year period of data collection. The data is also important because it contains 
longitudinal measures of client psychometric data following treatment entry. This data 
is useful for analysing changes in mental health and well-being during the course of 
withdrawal from various substances and the following initial weeks of abstinence that 
can contribute to a better understanding of co-morbidity. This study makes a 
significant contribution towards improved understanding of client factors predicting 
attrition and retention from TCs, including an improved understanding of the 
dynamics of client mental health functioning after initiating abstinence.  
 
 
Economic Costs of Substance Abuse 
Residential services have often been regarded as an expensive option for the 
treatment of substance abuse; however the higher cost of this form of treatment needs 
to be understood in the context of the overall cost to society of substance abuse. This 
section will present some estimates of the costs of substance abuse in various 
countries during recent decades. Determining the total costs of substance abuse is a 
complex task involving calculation of various direct and indirect costs to the 
individual and the state. This task is made especially difficult because substance abuse 
involves many substances including alcohol, tobacco, and various illicit substances. 
The related costs for all these substances are therefore, estimated in most cases, 
especially the various costs associated with illicit drug use. Although complex, cost 
determination of substance abuse is required to help guide policy makers and public 
health planners. Many countries report costs associated with alcohol use only, because 
the figures are more transparent and more easily determined than including costs of 
illicit substance abuse. 
The estimated 1998 annual costs of alcohol abuse in the United States of 
America (USA) were US$148 billion (Harwood, 2000). The added costs of other 
forms of substance abuse in the USA are likely to increase this figure significantly. 
For example, a RAND Corporation study reported that the 2005 costs of 
methamphetamine abuse in the USA was $23.4 billion (Rand Organisation, 2009). 
The costs of alcohol consumption to the United Kingdom’s (UK) National Health 
Service (NHS) in 2001 was estimated at 1.47 billion pounds, and increased to 2.7 
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billion pounds by 2006/2007 (NHS, 2010). The same 2010 NHS report notes that 
alcohol is the third leading cause of disease burden in developed countries. 
Thavorncharoensap, Teerawattananon, Yothasamut, Lertpitakpongand, and 
Chaikledkaew (2009) undertook a review of the cost of alcohol abuse in various 
countries, and suggested that the relative costs of alcohol consumption may be more 
easily understood when the costs are stated as a percentage of a country’s Gross 
Domestic Product (GDP). The authors report that in the 12 countries selected for their 
analysis, the economic burden of alcohol consumption equated to between 0.45 – 
5.44% of GDP for each country. 
A series of studies have been undertaken within Australia in recent decades to 
determine the total cost of alcohol, tobacco and other drug abuse that highlight the 
increasing costs of these problems to Australian society. The authors stated that 
almost one in every five deaths within Australia between 1988 and 1992 had drug-
related causes (Collins & Lapsley, 1996). A determination of the 1998/1999 costs by 
the same authors estimate tangible social costs of A$5.045 billion for illicit drugs, 
A$6.12 billion due to alcohol, and A$11.92 billion attributed to tobacco abuse 
(Collins & Lapsley, 2002). The most recent analysis by Collins and Lapsley (2008) of 
the total costs of tobacco, alcohol and illicit drug abuse within Australia during 
2004/2005 states that total costs for that year exceeded A$55 billion, and noted that 
tobacco accounts for A$31.5 billion, alcohol A$15.3 billion, and illicit drugs A$8.2 
billion. 
 A recent breakdown of Australian Government spending on illicit drug policy 
in 2002/2003 revealed that total costs were $3.2 billion, and that state governments 
accounted for approximately 70% of this spending. This figure was comprised of $1.3 
billion on proactive expenditure, of which 55% was devoted to law enforcement, 23% 
to prevention, 17% to treatment, 3% to harm reduction and 1% to activities spanning 
several of those areas (Moore, 2008). Expenditure on the consequences of illicit drug 
use was estimated to be another $1.9 billion, and the large majority of this amount 
was crime-related costs. The author notes that this illicit drug cost policy mix 
breakdown is very similar to cost breakdowns reported in other western countries. 
There is no evidence to suggest the costs of substance abuse have decreased in 
Australia and other countries in more recent years, and given the significant social and 
economic costs of substance abuse to these countries, there is no doubting the need to 
reduce costs where possible. Significant resources are devoted to education and policy 
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to control alcohol abuse, and policing, border protection, judicial and incarceration 
costs to reduce the supply of illicit substances. Another method of reducing the costs 
of substance abuse is to reduce on-going demand for substances by providing more 
effective substance abuse treatment programmes. There are various models of 
intervention for treating substance abuse and some of these models are resource 
intensive and require significant initial investment, and recurrent state and private 
funding.  
There have been no published comprehensive studies examining the cost-
effectiveness of substance abuse treatment in general within Australia; however 
Ciketic, Hayatbakhsh, Doran, Najman and McKetin (2012) recently completed a 
review within Australia of various treatments for methamphetamine abuse. The 
authors noted the difficulty of determining treatment efficacy due to the heterogeneity 
of treatments, the lack of treatment protocols by many treatment services, and the 
difficulty of consequently determining the cost-effectiveness of various treatment 
approaches. Further complicating an accurate determination of substance abuse 
treatment cost-effectiveness is the heterogeneity of treatment presentations by 
individuals who may or may not present with a wide range of comorbid physical and 
mental health problems that are likely to have significantly different treatment needs, 
and costs. Despite the limitations in determining the cost-effectiveness of various 
treatment interventions, in the last decade there has been considerable research 
examining the cost-effectiveness of various substance abuse treatment programmes in 
the USA and the U.K.  
A study of 43 Californian substance abuse treatment providers during 
2000/2001 reported that the average treatment cost per individual was $1,583, and 
that this was associated with a monetary benefit to society of $11,487 per treated 
individual, (Ettner, Huang, Evans, Ash, Hardy, Jourabchi, & Hser, 2006). The authors 
note this cost saving primarily represents a reduction in the cost of crime and 
increased employment earnings. However, there are many other unaccounted cost 
savings from improved health and quality of life for the individuals concerned. 
Despite this, the savings reported represent a greater than 7:1 ratio of benefits to costs, 
and the authors note that investment in substance abuse treatment is obviously cost-
effective. 
Potential cost savings from effective substance abuse treatment will generally 
be greater with young persons, however some research findings have reported specific 
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difficulties treating young persons for substance abuse problems because they are 
believed to be more likely to drop out of treatment compared with older clients (Hser, 
Grella, & Hubbard, Hsieh, Fletcher, Brown, & Anglin, 2001). Attempts to improve 
substance abuse treatment for adolescents have included the establishment of 
specialised substance abuse treatment services for adolescents; however, these 
specialist services are often expensive. King, Gaines, Lambert, Summerfield, and 
Bickman (2000) report a study of 428 adolescents that estimated the average 
treatment cost for each person was $13,067. The authors note, however, that for a 
subset of the young persons studied who were diagnosed with a comorbid disorder, 
the average treatment costs were more than double at $29,057. The authors note that 
comorbid mental health problems in adolescents with substance abuse problems 
presents more complex treatment demands that account for the higher average cost of 
treatment. Comorbidity is common in substance abuse populations and Chan, Dennis, 
and Funk (2008) report the findings of a large study involving 4,930 adolescents and 
1,956 adults admitted to various substance abuse treatment centres in the USA. They 
note that two thirds of clients had a co-occurring mental health problem in the year 
prior to treatment, and that young adults were found to be most vulnerable clients for 
having co-occurring mental health problems.  
There has been fast growing awareness of comorbidity in all age groups within 
the substance abuse treatment population field during the last decade. This has raised 
many questions for researchers, policy makers and clinical staff about treatment 
options, treatment effectiveness and cost-effectiveness of various substance abuse 
programs in meeting the needs of clients with complex substance abuse problems. 
Determining the cost-effectiveness of substance abuse programs has therefore also 
needed to account for the fact that a large proportion of the presenting population 
have more than one disorder, and that analyses of treatment effectiveness should 
consider the effects of intervention across multiple domains in client lives to more 
accurately determine the potential costs and cost savings of suitable treatment. 
 
Measuring Substance Abuse Treatment Effectiveness 
The topic of evaluating treatment effectiveness has been a complicated and 
contentious issue in the substance abuse treatment field for many years (Sindelar, 
Jofre-Bonet, French, & McLellan, 2004). The authors note that many service 
providers and researchers believe treatment effectiveness should be measured on a 
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single scale, which is achieving and sustaining abstinence from substance abuse. The 
goal of abstinence in these more traditional substance abuse treatment programmes is 
determined from a philosophy of treatment that is commonly termed the “disease 
model”. For example, Alcoholics Anonymous and Narcotics Anonymous are two 
large organisations operating in many western countries within the substance abuse 
treatment field that suggest that abstinence is the only acceptable goal of treatment.  
Much research into addictive behaviours published in recent decades 
suggested that brief returns or “lapses” to substance abuse are part of the process of 
unlearning chronically habitual behaviour, and do not necessarily represent failure or 
relapse (Saunders & Houghton, 1996). This recognition that recovery from substance 
abuse treatment is a process over time has led to the acceptance and adoption by many 
public policy makers and treatment programmes of the legitimacy of harm 
minimisation goals rather than abstinence as the only acceptable goal for substance 
abuse treatment services.  
Harm minimisation philosophy recognises that many individuals are either 
unable, or unwilling, to stop using various substances completely, therefore harm 
minimisation treatment goals may be utilised to reduce the level of substance use so 
there is less disruption in the person’s life. Another common harm minimisation goal 
might be to ensure that their drug use is safe, and this may typically involve teaching 
people about safe syringe use and disposal to reduce the risk of blood-borne disease. 
Researchers have recognised that it is more appropriate to measure substance abuse 
treatment effectiveness across multiple domains, including reduced drug use, 
improved psycho-social functioning, reduced crime and increased employment 
(Sindelar et al., 2004). This issue of appropriate treatment goals often overlaps with 
common differences between the clinical aims of inpatient versus outpatient treatment 
programmes. Inpatient services generally retain the goal of abstinence from all 
substance abuse, at least during the inpatient programme, whereas many outpatient 
programmes adopt harm minimisation or substance use reduction goals. An 
Australian review of long-term residential treatment services reported that 66% of the 
56 Australian services reviewed reported having an abstinence treatment philosophy 
(Ernst & Young Consulting Team, 1996). The following section will briefly describe 
what is meant by inpatient or residential substance abuse treatment services. 
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Residential Substance Abuse Treatment 
Residential services play an important role in providing substance abuse 
treatment in the USA and the UK, and other western countries (Gossop, Marsden, 
Stewart, & Rolfe, 1999). The cost-effectiveness of residential substance abuse 
treatment services has been queried, however, because it is generally regarded as 
more expensive than outpatient treatment. In response to those claims, McGeary, 
French, Sacks, McKendrick, and DeLeon (2000) report that when the costs of 
increased number of hospital days and emergency visits by outpatient clients were 
considered, residential treatment and outpatient treatment costs were similar.  
Other studies of inpatient treatment for substance abuse have focused on 
whether inpatient treatment is more effective than outpatient treatment or drug 
substitute modalities such as methadone programmes. Mattick, Baillie, Grenyer, Hall, 
Jarvis, and Webster (1993) reported there is limited evidence to suggest inpatient 
treatment for alcohol problems was more effective than outpatient treatment. More 
recently, however, the Drug Outcome Research in Scotland study (DORS) noted that 
clients in residential services were more likely to achieve 90 day abstinence rates than 
clients in all other forms of substance abuse treatment (McKeganey, Bloor, 
Robertson, Neale, & MacDougall, 2006). There is also the realisation that poor people 
with no employment and insecure housing may benefit more from residential 
interventions than they would benefit from outpatient interventions.  
There are complexities when comparing substance abuse treatment modalities, 
because client treatment goals may differ greatly, effectiveness is measured 
differently by different modalities and programmes, and there are high levels of 
heterogeneity in programs even with a similar modality (Ettner, Huang, Evans, Ash, 
Hardy, Jourabachi, & Hser, 2006). Researchers also need to follow up clients to 
determine post-treatment outcomes; however this is difficult as client populations are 
often homeless and difficult to maintain in longitudinal research programmes. Despite 
these difficulties in obtaining meaningful comparisons of treatment outcomes of 
different treatment modalities, several studies have reported that residential treatment 
services are more effective than outpatient services engaging persons with co-morbid 
mental health problems and those with housing problems (Nuttbrock, Ng-Mak, 
Rahav, & Rivera, 1997; McKeganey et al., 2006). Etheridge, Hubbard, Anderson, 
Craddock, and Flynn (1997) also note that persons with more severe substance abuse 
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problems are more likely to require more intensive interventions than what is 
normally offered in community settings. 
It should also be noted that residential treatment for substance abuse can take 
various forms. In some situations the residential service is provided by a public or 
private clinic or hospital where detoxification or medically-managed withdrawal 
occurs initially, and is then typically followed by a period of individual and group 
counselling in the clinic or hospital. These clinic and hospital-based programs tend to 
be shorter-term programs of only a few weeks duration, and are often utilised by 
persons with more social support, and a more structured life including stable 
employment and housing. Other residential treatment programmes are designed to 
cater for persons with more complex problems and these programmes may have a 
residential duration of between 28 days to a year of more. Many of these longer-term 
residential programmes are described as therapeutic communities, and the following 
section will describe this specific type of residential treatment service and some of the 
research findings relating to their effectiveness. 
 
Therapeutic Communities 
Therapeutic communities (TCs) have existed in the substance abuse treatment 
field for about 50 years. TCs are a specific form of substance abuse treatment using 
residential programs structured in a hierarchical manner involving various treatment 
stages reflecting increasing levels of personal and social responsibility. TCs primarily 
differ from other styles of residential substance abuse treatment by their use of staff 
and residents as key agents of change with an approach that has been termed 
“community as method” (De Leon, 2000, p. 92).  TCs typically use a hierarchical 
model of treatment that occurs in several stages with the aim of increasing residents’ 
personal and social responsibility (NIDA Research Report, 2002). TCs have become a 
common form of residential treatment for substance abuse in many western countries; 
however their cost-effectiveness has been questioned over the decades. 
Gowing, Cooke, Biven, and Watts (2002) reviewed the TC outcome literature 
and reported that there is little evidence to support the claim that TCs are more 
effective than other forms of substance abuse treatment. The authors did note, 
however, that there was substantial research evidence that TC treatment is associated 
with reduced drug use and criminality, improved health and psychological 
functioning, and increased involvement in work, education and training. Lees, 
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Manning, and Rawlings (2004) undertook a meta-analysis of 29 published studies of 
TC treatment effectiveness where TC programs had been compared with various other 
control interventions or control institutions. The authors noted several difficulties 
obtaining randomised controlled trials of TCs in the published literature, especially 
given that TC entry criteria may be complex and that the variety of treatment 
outcomes that may be chosen for comparison in different studies. Despite these 
limitations, they note that their analysis indicated that most published studies reported 
that TC treatment outcomes were more effective than the various control programs 
and institutions across the multiple domains compared. 
There have been many studies in the last two decades reporting that the style 
of treatment practised in therapeutic communities has adapted to suit changing 
substance abuse populations and funding requirements. In particular, the recognition 
that many individuals seeking substance abuse treatment have mental health 
difficulties has required many TCs to specialise or modify their normal practices. The 
specialised TCs are often referred to as “modified TCs” and they usually have a less 
demanding program structure with reduced emphasis on confrontational group work 
(De Leon, 2000). Brunette, Mueser, and Drake (2004) undertook an analysis of 
controlled studies of AOD residential services including many TCs, and noted that 
TCs were more effective in helping persons with multiple problems (especially clients 
with comorbid mental health problems) if they were able to appropriately integrate 
mental health services within their substance abuse service. There has been 
considerable research in recent decades to determine how to better engage, assess, 
treat and retain comorbid populations in residential substance abuse treatment 
services, including TCs. 
Sacks, Banks, McKendrick, and Sacks (2008) report a recent analysis of four 
studies comparing various forms of standard treatment versus treatment within 
therapeutic communities that had been modified for clients with co-occurring severe 
mental health disorders. The authors note that the modified TCs had better treatment 
outcomes for clients with mental health comorbidities across several measures and 
domains including substance use, mental health, crime, HIV risk, employment and 
obtaining stable housing after treatment. The authors also note that the differences in 
outcomes varied between studies and further research is required to better clarify the 
factors that contribute to treatment effectiveness with this population. 
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TC outcome research indicates that the most consistent indicator of positive 
treatment outcomes in all modified and standard TC programmes is the amount of 
time the person spent in treatment (Greenfield, Burgdorf, Chen, Porowski, Roberts, & 
Herrell, 2004). In particular, 90 days has often been reported in recent decades as the 
minimum time that should be spent in a TC or residential service to be of benefit 
(Baker, Gowing, Lee, & Proudfoot, 2004; Messina, Wish, & Nemes, 2000). Various 
factors have been hypothesised to influence TC treatment retention, and the following 
section will discuss these substance abuse treatment retention research findings. 
 
Treatment Retention 
Many researchers have reported that the amount of time spent in inpatient 
substance abuse treatment is positively correlated with successful treatment outcome 
where abstinence is the given definition of success (De Leon, Melnick, Kressel, & 
Jainchill, 1994; Hubbard, Craddock, & Anderson, 2003; Simpson, Joe, Fletcher, 
Hubbard, & Anglin, 1999). Brewer, Catalano, Haggerty, Gainey, and Fleming (1998) 
report the results of a meta-analysis of opiate treatment studies in which short periods 
of treatment (less than 8 weeks) and leaving treatment prematurely were significant 
predictors of substance abuse relapse. Although time in treatment appears to be the 
strongest predictor of successful substance abuse treatment outcome, Baker, Gowing, 
Lee, & Proudfoot (2004, p.80) note, “but this is a complex issue with time being 
something of a proxy indicator for engagement, participation and progress in 
treatment.” There is general agreement among researchers in this field that the amount 
of time in AOD treatment programs is a strong predictor of successful outcome, 
however there remains mixed findings of the client factors hypothesised to predict 
treatment attrition. The following sections discuss some of the client factors that have 
been commonly reported by researchers as predicting AOD treatment attrition. 
 
Retention and Gender 
Women are often under represented in AOD treatment research studies with 
researchers noting existing substance abuse treatment models have been informed by 
primarily studying men (Sun, 2006). Many studies have reported that women are 
more likely than men to drop out of inpatient substance abuse treatment prematurely 
(Copeland & Hall, 1995; De Leon et al., 1994; Haller, Miles, & Dawson, 2002). It has 
also been suggested that female substance abuse is closely linked to comparatively 
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poorer psychological functioning with higher rates of co-morbidity, especially 
depression and suicidal ideation (Allen, 1994; Copeland & Hall, 1995; Hser, Huang, 
Teruya, & Anglin, 2004; Wilke, 2004).  
Messina, Wish, and Nemes (2000) analysed data from 412 clients (116 
females and 296 males) who had sought substance abuse treatment and were 
randomly assigned to two different TCs followed by a period of outpatient care. Both 
men and women who completed the longer 12 month program were much less likely 
to relapse, commit crime or be unemployed, compared to males and females who 
attended the shorter six month TC program. The authors noted that the women in this 
sample had been abusing drugs for approximately 10 years with a high degree of 
previous criminal involvement and appeared to benefit from longer-term residential 
services more than the males in the sample. There were no significant gender 
differences for completion of the longer 12 month program. 
Greenfield, Brooks, Gordon, Green, Kropp, McHugh, Lincoln, Hien, and 
Miele (2007) reviewed the substance abuse treatment outcome literature from 1975 to 
2005. They noted that almost half the number of women compared to men develop 
substance abuse problems, and are much less represented in substance abuse treatment 
populations and related research studies. The authors also noted that, when women do 
seek treatment, they often present with more severe mental health and social 
problems, and may have different needs compared to males in treatment. Greenfield et 
al. (2007) found no evidence that women-only substance abuse treatment programmes 
were more effective for women than mixed-gender programmes, but did note there 
was considerable evidence that addressing specific needs of women within mixed-
gender programmes is effective. The authors found that, once in treatment, gender is 
not a significant predictor of treatment retention, completion or outcome. Sun (2006) 
reviewed the substance abuse treatment literature, and reported findings of 35 women-
only treatment services and studies with separate gender findings from mixed-gender 
treatment services. The author notes that nine studies reported that women only 
programs had better treatment retention than mixed-sex programs, but notes that most 
of the studies had significant design limitations.  
In summary, there does not appear to be consistent findings that gender-
specific treatment services reliably produce improved treatment retention or other 
improved treatment outcomes. More recent research has focused on the specific needs 
of females in substance abuse treatment including program factors hypothesised to 
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affect female retention in residential treatment. In general, there has been little 
published research on Australian substance abuse residential treatment samples 
comparing treatment attrition rates of males and females. Specifically, there is little 
published Australian research examining gender differences in psychological 
functioning during residential treatment for women with substance abuse problems. 
 
Retention and Age 
Client age has often been noted as a factor predicting treatment outcome 
following substance abuse treatment. It is commonly believed by many AOD 
treatment clinical staff that older clients have more likely “hit bottom” (this is a term 
often used in the AOD treatment field to describe the client with an overwhelming 
number of problems in multiple domains of their life due to their substance abuse). It 
is commonly believed that these older clients are more likely to be motivated to 
complete treatment than younger clients with less complex problems. Supporting 
these common AOD staff perceptions that older clients are usually more motivated to 
undertake and complete treatment than younger clients are research findings that 
adolescents and young adults are less likely to be retained in substance abuse 
treatment programmes (Williams & Chang, 2000).  
Grella, Hser, Joshi, and Anglin (1999) reported on the Drug Abuse Treatment 
Outcome Studies (DATOS) that analysed outcomes of 551 clients in long-term (12 
months) residential services with outcomes of 571 clients in outpatient programs. The 
authors found that younger clients (less than 30 years) stayed in treatment for fewer 
days than older clients in both outpatient treatment counselling and residential 
modalities. The authors suggested that, although retaining younger clients in treatment 
was more difficult, the benefits of retention for long-term treatment success were 
apparent and therefore the problem of retaining younger persons in treatment needed 
to be better understood. Joe, Simpson and Broome (1999) also analysed the DATOS 
findings and reported that younger clients tended to remain less days in treatment for 
all substance abuse treatment modalities. 
Recent research by Adams, Peden, Hall, Rayens, Staten, and Leukefeld (2011) 
of female offenders in a community-based residential substance abuse facility 
indicated that older women were much more likely to remain in treatment than 
younger women, although the authors note that this was a particularly vulnerable 
population with concerns about future employment. Satre, Mertens, Arean, and 
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Weisner (2004) followed up 925 former clients 5 years after treatment and reported 
outcomes according to client age. The authors found that older adults (55-77 years) 
had been retained in treatment longer than middle-aged (40-54 years) or younger (18-
39 years) clients, and the older client group were more likely to be abstinent 5 years 
later than younger and middle-age groups. Analysis of these outcomes revealed that 
age group was not the most significant factor predicting 5-year outcomes, and that 
other variables such as gender, treatment retention, primary drug of abuse and social 
networks had greater effect in predicting 5-year AOD abstinence rates. Although there 
are obviously other confounding factors affecting long-term outcomes, there remains 
the common finding that younger persons tend to remain in most AOD treatment 
modalities for shorter periods of time compared to older clients. 
 
Retention and Self-Esteem 
Various client attributes have been studied to determine if there are possible 
links to the aetiology of substance abuse, and recovery from substance abuse. 
Research has indicated that low self-esteem in both men and women is implicated in 
the development of alcohol use disorders, and women with low self-esteem are also at 
risk of developing drug use disorders (Trucco, Connery, Griffin, & Greenfield, 2007). 
Low self-esteem has been associated with alcohol and other drug abuse with 
researchers noting that low self-esteem is common in both outpatient and inpatient 
treatment populations (Malcolm, 2004). Females presenting for maintenance 
treatment for opiate abuse have reported lower self-esteem than men, and this was 
suggested to be closely related to the high rate of depression in women seeking 
substance abuse treatment (Giacomuzzi, Riemer, Ertl, Rossler, Hinterhuber, & Kurz, 
2005). 
In recognising that persons low in self-esteem are more at risk of developing 
substance abuse problems, increasing client self-esteem is often included as a goal in 
substance abuse treatment interventions. However, the relationship between changes 
to client self-esteem and successful substance abuse treatment is unclear. 
Improvement in self-esteem scores during substance abuse treatment for women 
appears to be an important factor predicting treatment success (Wilke, 2004), but the 
findings for males are less clear. Malcolm (2004) reported on a sample of homeless 
men receiving outpatient substance abuse treatment where self-esteem scores 
decreased concurrent with a general decrease in the group’s alcohol and other drug 
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use. Hawke, Hennen, and Gallione (2005) reported outcomes from a study of 185 
adolescent males from five New Jersey therapeutic community programs, and note 
that a measure of therapeutic involvement was a strong predictor of treatment 
retention and outcome. The measure of therapeutic involvement was comprised of 
numerous factors, but further analyses indicated that self-esteem was a strong 
component predicting therapeutic involvement and retention.  Dekel, Benbenishty, 
and Amran (2004) reported that both male and female clients with higher self-esteem 
were more likely to be abstinent at 15 months post-treatment compared to clients with 
lower self-esteem in a study of 167 heroin addicts from 3 TCs in Israel.  
Trucco et al., (2007) conducted a relatively small study (41 women and 60 
men), but provided an interesting analysis of the association of self-esteem with 
substance abuse treatment. The authors reported that at treatment entry low self-
esteem was associated with depression and other psychiatric disorders in both men 
and women, but that self-esteem was not related to relapse or one-year post treatment 
drinking outcomes, gender or self-efficacy. They further noted that the definition of 
self-esteem is unclear and that many studies have collapsed measures of self-efficacy 
with self-esteem and self-concept. 
The research suggests that self-esteem scores may be an important predictor of 
treatment retention and attrition for female and younger clients in particular. 
However, the mixed findings reported in the literature suggest that the relationship 
between self-esteem and substance abuse treatment completion requires further 
clarification. Many studies of substance abuse treatment retention and client self-
esteem have also noted a strong relationship between client self-esteem and 
concurrent measures of anxiety and mood. 
 
Retention and Anxiety and Mood Disorders 
The most common coexisting disorders with alcohol and other substance 
abuse are anxiety and affective disorders (Donohue, Acierno, & Kogan, 1996; Scott, 
Gilvarry, & Farrell, 1998). Scott et al. (1998) reviewed the findings of clinical 
samples from the United Kingdom and reported that 28% of individuals with a 
substance abuse problem will also have an anxiety problem, and 26% will have an 
affective disorder. McKenna and Ross (1994) estimated that at least 50% of 
individuals who abuse alcohol and/or other drugs have at least one comorbid 
psychiatric disorder. The National Survey of Mental Health and Wellbeing 
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(NSMHWB) undertaken with an Australian population in 2007 noted high rates of 
comorbidity between alcohol and other drug use disorders and mental health issues 
(Mills, Deady, Proudfoot, Sannibale, Teeson, Mattick, & Burns, 2007). The authors 
reported that the most common comorbid mental health issues in the population 
abusing alcohol and other drugs were mood, anxiety and personality disorders. 
Many drug treatment retention/attrition studies have reported that clients with 
substance abuse and psychiatric comorbidity have higher rates of treatment attrition 
and relapse (Charney, Paraherakis, Negrette, & Gill, 1998; Miller, 1992; Moos, 
Mertens, & Brennan, 1994). However, Meier and Best (2006) reported an analysis of 
United Kingdom residential treatment services for substance abusers and noted that 
the proportion of dual-diagnosis rates within these samples did not appear to influence 
retention rates. A review of 58 treatment outcome studies undertaken by Meier and 
Barrowclough (2009) provides a recent summary of research on this question. The 
authors noted that a past history of mental health problems did not predict treatment 
attrition. However, evidence for current mental health problems affecting substance 
abuse treatment attrition was contradictory. They noted that most treatment retention 
research studies have focused on the effects of affective disorders, anxiety disorders 
and personality disorders as they are the most common mental health problems 
reported by the majority of studies. They note that most clients in substance abuse 
treatment with concurrent anxiety, mood and most personality disorders are not more 
likely to drop out, however clients with anti-social personality disorder are at elevated 
risk of attrition.  
The high prevalence of current comorbidity in substance abuse treatment 
populations is nevertheless reported by many researchers to contribute to low 
treatment retention rates, and it is often noted that psychiatric disorders need to be 
accurately identified and addressed during substance abuse treatment to improve 
retention rates. As previously described, during the last 20 years many therapeutic 
community programmes have modified the style and content of their programmes 
with the aim of improving retention rates for clients with mental health problems. 
Tailoring interventions in therapeutic communities to better retain residents with 
mental health problems suggests the need for accurate diagnoses, however obtaining 
definitive mental health diagnoses is often complicated with substance abusing 
populations.  
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Co-existing Versus Substance-induced Disorders 
Several researchers dispute the high prevalence figures reported for current 
psychiatric comorbidity in substance abuse treatment populations (Charney et al., 
1998; Grant et al., 2004; Raimo & Schuckit, 1998). Curran, Booth, Kirchner, and 
Deneke (2007) stated that, in the case of mood disorders, many studies have failed to 
distinguish coexisting disorders from temporary symptoms of substance intoxication 
and withdrawal because assessment is usually undertaken on admission to treatment, 
soon after or during the substance abuse withdrawal period. They noted that 
significant positive change in patient psychopathology usually occurs in the 
immediate weeks following admission to substance abuse treatment and suggested 
that these cases are not representative of mood disorders independent from the 
substance abuse problem. 
More accurate prevalence rates of comorbidity in substance abuse treatment 
populations would be better determined by measuring anxiety and depressive 
symptoms following the withdrawal period from substance abuse. Curran et al. (2007) 
suggest the discrimination between major depressive episodes and substance-induced 
mood disorders requires a detailed time-line evaluation of the client, but note that 
most symptoms of substance-induced depression resolve within four weeks of 
abstinence. Baker, Kay-Lambkin, and Lee (2009) note the high frequency of anxiety 
and mood disorders in substance abuse treatment populations suggests screening for 
these problems should be undertaken in AOD treatment services. The authors make 
the important note that this should be undertaken with assessment tools that have been 
specifically validated for use with alcohol and other drug service clients after the 
clients have completed the active phase of substance use withdrawal. 
Many studies have noted that females have high depression levels at treatment 
entry, but there are a limited number of studies examining treatment retention and 
changes in psychopathology in substance abuse treatment populations that include 
female participants (Brooner, King, Kidorf, Schmidt, & Bigelow, 1997; Greenfield et 
al., 2007). Curran et al., (2007) reported on a male sample showing elevated 
depression scores at treatment exit are a predictor of relapse within three months of 
treatment cessation, but noted that elevated depression scores at treatment entry in this 
sample did not reliably predict treatment attrition. 
A recently published  analysis of 227 cocaine dependent individuals in 6 TCs 
in Spain reported high rates of co-occurring psychiatric morbidity for these persons 
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(65.6%), with mood, anxiety and psychotic disorders predominating. The authors 
describe the use of a semi-structured questionnaire designed to help discriminate 
independent or primary psychiatric disorders, from substance-induced disorders. They 
were consequently able to determine that the large majority of both mood and 
psychotic co-occurring psychiatric disorders were substance-induced psychiatric 
disorders. The authors note that the finding has important ramifications for how 
integrated mental health treatment should be implemented within TCs to best effect 
(Vergara-Moragues, Gonzalez-Saiz, Lozano, Espinosa, Calderon, Bilbao-Acebos, 
Garcia & Garcia, 2012). In regard to the implementation of integrated mental health 
treatment within substance abuse treatment settings, Sterling, Chi & Hinman (2011) 
note that although there is considerable evidence for the benefits of integrated mental 
health care, a variety of practical and ideological barriers remain within many U.S. 
substance abuse treatment settings, and note that only about half of the U.S. AOD 
services offer dual AOD and mental health treatment. The authors note that some of 
these barriers may relate to the primary form of substance abuse that services treat, 
and the next section focuses on reported findings of primary drug of abuse and 
treatment retention.  
 
Retention and Primary Drug of Abuse 
Persons entering substance abuse treatment programmes are usually required 
to indicate to the service the primary drug or substance that has been problematic for 
them in recent times, and this is usually termed the person’s “primary drug of abuse”. 
Treatment services typically service populations where various substances have been 
indicated as the “primary drug of abuse”, and recognise that persons often abuse 
multiple substances. Most residential services therefore do not alter or tailor the 
treatment programme according to the person’s identified primary drug of abuse.  
However, many service staff believe people gravitate to the use and abuse of specific 
substances for various personal reasons that may or may not be effectively addressed 
in a particular treatment programme. Many researchers have hypothesised that an 
individual’s primary drug of abuse may be important in determining whether the 
person remains in treatment, however the research findings regarding whether a 
person’s primary drug of abuse helps predict their retention in various forms of 
substance abuse treatment have been mixed. 
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There were no significant differences reported by Copeland and Sorensen 
(2001) in a North American sample regarding the successful completion of outpatient 
treatment for stimulant users in a study comparing cocaine and methamphetamine 
users. Patkar, Thornton, Mannelli, Hill, Gottheil, Vergare, and Weinstein (2004) 
measured treatment outcomes of 143 individuals receiving 12-week substance abuse 
outpatient treatment and noted no significant differences in treatment completion rates 
when comparing the alcohol, cocaine and multi-substance abusing groups. More 
recently, however, Meier and Best (2006) conducted a survey of 57 AOD residential 
rehabilitation services in England and Wales, and noted that treatment completion 
rates were significantly lower for programmes with more clients admitted for illicit 
drug problems than for alcohol problems. There does not appear to be any consistent 
finding reported in the literature for any particular primary drug of abuse affecting 
treatment retention. 
The majority of AOD treatment attrition studies in the previous twenty years 
have been undertaken in either the USA or Western Europe and have focused on 
populations where alcohol, opiates and cocaine were the primary drugs of abuse. 
There is increasing concern during the last two decades about methamphetamine 
abuse in Australia, North America and many Asian countries, and yet there has been 
limited research undertaken with clients presenting to Australian inpatient treatment 
facilities with this class of drug as the primary presenting drug problem (Australian 
Institute of Health and Welfare, 2002). There has been considerable research 
undertaken in North American with this particular population group during the last 
decade. Luchansky, Krupski, and Stark (2007) studied all adults and youth admitted 
to Washington State substance abuse treatment services in 2003. They found that both 
adult and youth clients who identified methamphetamines as their principal drug of 
use had shorter episodes of both inpatient and outpatient treatment, and were less 
likely to have positive outcomes compared to clients identifying alcohol and cannabis 
as their primary drug of abuse. Hillhouse et al., (2007) reported findings from their 
study of 420 methamphetamine abusing adults that females and persons with high 
depression levels were less likely to successfully engage with substance abuse 
treatment for methamphetamine abuse. The authors also noted there has been little 
published research identifying predictors of treatment retention and completion with 
methamphetamine abusing populations. 
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Retention and Methamphetamines  
There is limited understanding of comorbidity and psychopathology change 
following abstinence with methamphetamine treatment populations in particular 
(Dawe & McKetin, 2004). Few substance abuse inpatient treatment population studies 
have reported changes in psychopathology during treatment, and even fewer have 
examined gender differences in psychopathology change. A focus on changes in client 
psychopathology within the methamphetamine-abusing treatment population is also 
rare within the research literature. Dyer and Cruickshank (2005) reported findings of 
an analysis of methamphetamine abusing clients seeking detoxification in Western 
Australia, and reported moderate to high levels of depression in this sample, however 
the authors noted that further research is required to further determine the relationship 
between depression and treatment outcome with this population.  
Rawson et al., (2000) found that methamphetamine users reported 
significantly higher depression scores than cocaine users and that these elevated 
scores persist for longer periods of time and negatively affect treatment retention. 
These authors noted that elevated depression scores persist among some former 
methamphetamine abusers even years after treatment. In contrast to this report of 
persistent elevated depression scores among former methamphetamine abusers, 
McGregor et al., (2005) stated that the majority of withdrawal symptoms with 
methamphetamine users resolve within the first week of withdrawal, including 
depression symptoms. This study only involved a small sample (n = 21) that included 
a single female participant. Lin et al., (2004) conducted a larger study of incarcerated 
Taiwanese methamphetamine users (n = 325, including 145 females), where 37% of 
the sample reported psychiatric problems. No significant gender differences were 
reported for mood disorders with this sample; however there was no analysis of 
psychopathology change following drug use cessation.  
A review of relevant literature by Baker and Dawe (2005) focussed on 
describing the prevalence and course of the most common co-occurring psychological 
problems with methamphetamine users. These authors state there has been very little 
investigation of the psychopathology course of methamphetamine use and co-
occurring psychological problems. They also note that diagnostic certainty requires a 
substantial period of abstinence. Baker and Dawe (2005) also state that 
psychopathology scores should be measured at least 2 weeks after initiation of 
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abstinence, and preferably measured repeatedly during treatment to better determine 
the role of depression and anxiety in treatment retention.  
Gonsalves, Sapp and Huss (2007) report findings of a recent study comparing 
methamphetamine and non-methamphetamine users entering a U.S. short-term 
residential dual diagnosis treatment facility, and note that the methamphetamine sub-
population were more likely to be younger, and to drop out of treatment early 
compared to non-methamphetamine users.  Darke, Kaye, McKetin, and Duflou (2008) 
report a review of the major physical and psychological harms of methamphetamine 
use, and note that compared to normal populations, high rates of substance-induced 
psychosis, depression and anxiety are reported by users.   
Ciketic, Hayatbakhsh, Doran, Najman, and McKetin (2011) report an analysis 
of the effectiveness of various outpatient and inpatient treatment interventions for 
persons with methamphetamine problems, and note that there are very low rates of 
methamphetamine treatment access within Australia despite the fact that Australia has 
one of the highest rates of methamphetamine use in the world. It remains possible that 
these low treatment rates of methamphetamine users within Australia may reflect that 
treatment services are not meeting the mental health needs of this client group, and 
therefore methamphetamine users who do access treatment are therefore more likely 
to drop out. 
 
Retention and Prescribed Psychoactive Medication  
Determining a more accurate clinical picture of client psychopathology after 
in-patient entry has important ramifications for treatment content and service policy. 
An accurate determination of whether a mood disorder exists or is primarily a short-
term function of substance withdrawal may help determine whether continued specific 
psychological or pharmacological interventions are warranted.  
Until relatively recently, the use of medication for mental health disorders was 
discouraged or disallowed in many substance abuse treatment settings in the USA 
(Brady & Verdun, 2005). Knudsen, Ducharme, and Roman, (2007) conducted  a more 
recent national study of 766 substance abuse treatment centres in the USA, and noted 
that less than half of these treatment centres allowed client use of SSRI medications 
for mood disorders. The frequency of use of prescribed medication for psychiatric 
disorders within Australian residential AOD treatment facilities is more difficult to 
determine, because there has been little published research of Australian residential 
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treatment services in general, and what has been published usually does not indicate 
whether clients are allowed prescribed medication use during residential treatment. 
The difficulty with some AOD residential treatment services prohibiting the 
use of prescribed psychoactive medications is that, many persons seeking to enter 
“drug free” residential AOD treatment services will abruptly cease taking prescribed 
medications to qualify for entry. One problem with abrupt cessation of prescribed 
psychoactive medications immediately prior to residential service entry is many 
individuals may experience substance abuse withdrawal symptoms with 
accompanying increased mental distress symptoms. Escalation of mental symptoms 
and decreased mental well-being due to entry to a novel environment, concurrent with 
withdrawal from substance use and various prescribed medications may possibly 
contribute to the high rates of early treatment attrition witnessed in many residential 
AOD treatment services.  
Lynskey (1998) reported that a number of placebo-controlled studies have 
indicated treatment for alcohol dependence may be enhanced with anti-depressant 
medication. The large majority of AOD treatment studies focusing on attrition rates in 
residential services do not indicate whether prescribed psychoactive medications are 
available to clients. It is possible that reported treatment attrition rates are influenced 
by service policy regarding the exclusion or availability of prescribed medications for 
clients experiencing mental health problems (Knudsen, Ducharme, & Roman, 2007). 
 
Summary 
Most analyses of AOD residential treatment services (including therapeutic 
communities) conclude that residential treatment is an effective form of intervention 
for individuals with various substance abuse problems. High treatment attrition rates 
in residential interventions are common however, and many studies have therefore 
sought to identify causes of attrition from residential substance abuse treatment. 
Various client and program factors have been identified in individual studies that 
predict client attrition; however, there is no consensus of what are reliable attrition 
factors, and the search for factors influencing attrition is complicated by many 
variables. Some of the attrition factors that have been identified in the literature 
include client gender, age, mental health status, and primary drug of abuse.  
There are a large number of studies examining retention and attrition in 
residential treatment settings in the USA, and a smaller number of studies of United 
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Kingdom and other European treatment services, but little published literature 
examining client retention and attrition in Australian AOD residential or TC treatment 
services. It is important to undertake research with Australian TC treatment services, 
as there are different population mixes and some different patterns of substance abuse 
compared to other countries that may influence client treatment retention.  
In recent years there have also been numerous research findings stating that 
persons entering residential treatment with methamphetamine-use problems are much 
more likely to drop out of treatment, and that many of these clients have comorbid 
mental health problems. Australia continues to have high rates of methamphetamine 
use, and so this study also seeks to better understand if methamphetamine-using 
clients are at much higher risk of TC attrition. The second stage of this study involved 
presenting the findings of the first stage to experienced managers and senior clinicians 
of Australian and New Zealand TCs for comment and reaction. The primary aim of 
the second stage is to help determine the validity and utility of the stage one findings 
from the perspective of TC senior staff, and to explore possible barriers and solutions 
to introducing knowledge of the stage one findings to TCs. 
 
Stage 1 Research Aims 
It is possible, on the basis of past findings, to hypothesise that gender, age, 
primary drug of abuse and client psychopathology are factors that may influence 
AOD inpatient treatment attrition. However, past findings are inconsistent in their 
identification of whether these factors influence inpatient treatment attrition. The aim 
of the first study reported in this thesis was to examine several of these previously 
reported predictors of retention and attrition in an Australian therapeutic community. 
More specifically the study aimed to examine the association between gender, age 
group, primary drug of abuse, medication use, self-esteem, anxiety and depression 
scores at entry, at 2-weeks and at 8-weeks, and treatment retention at 8 and 14 weeks, 
and explore hypotheses generated from past research findings. 
Hypothesis 1 is that both male and older clients will be more likely retained in 
treatment at both 8 weeks and 14 weeks. 
Hypothesis 2 is that clients nominating methamphetamines as their primary 
drug of abuse will be more likely to drop out of treatment by 8 weeks and 14 weeks. 
Hypothesis 3 is that clients with elevated anxiety and depression scores will be 
more likely to remain in treatment at 8 weeks and 14 weeks. 
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Stage 1 Method 
Participants  
The sample consisted of 234 adults (150 males, 84 females) who voluntarily 
entered a Western Australian therapeutic community (Palmerston Farm) during a six-
year period (2000-2005). The agency client database for the period of data collection 
contains no personal-identifying information and is comprised of client data 
indicating age, gender, primary substance of abuse, medication use, and psychological 
test scores (depression, anxiety and self-esteem), that were collected by the agency for 
client monitoring purposes throughout the period of clients’ substance abuse 
treatment.  
The client demographic data were routinely collected by administrative staff 
soon after client entry to the TC program. The psychometric data were collected by 
clinical staff at entry, and then re-measured during the second, eighth and fourteenth 
weeks of remaining clients. The psychometric data remained in client files to allow 
clinician monitoring of client mental health throughout their period of treatment. 
Agency staff transcribed client demographic and psychometric data from client files 
on an annual basis, and this de-identified information was electronically stored on a 
secure, dedicated archive at the agency.  This author was later granted access by the 
Chief Executive officer of the Agency to use the de-identified client data archive for 
the purpose of this research.  
 
Participant Demographics 
 
Client Age 
Preliminary analysis of the frequencies of the treatment entry data resulted in 
the decision to separate the data into three age groups of approximately even numbers. 
These three categories are; 17-23 years inclusive (n = 77), 24-29 years (n = 80) and 
30-50 years (n = 77). 
 
Client Gender 
 There were 150 males and 84 females at treatment entry. 
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Stage 1 Materials 
 
The psychometric measures of anxiety, self-esteem and depression were selected by 
the drug treatment agency involved due to their availability at no charge, and their 
recommendation for AOD agency use by the Western Australian Best Practice in 
Alcohol and Other Drug Interventions Working Group’s publication: “A Guide for 
Counsellors Working with Alcohol and Other Drug Users” (Marsh & Dale, 2000). 
 
 
Self-esteem 
 
• Rosenberg Self-Esteem Scale (RSE) - (Rosenberg, 1989). 
The Rosenberg Self-Esteem (RSE) Measure is a 10-item, 4-point scale measure, 
originally designed to measure the self-esteem of high school students. However, 
since its development in 1965 the scale has been used with many different populations 
from a large variety of occupations. Extensive research has demonstrated concurrent, 
known-groups, predictive and construct validity of the RSE, and it correlates highly 
with other self-esteem measures, and in predicted directions with commonly used 
measures of anxiety and depression. The RSE has a Guttman scale coefficient of 
reproducibility of .92, indicating excellent internal consistency, and 2-week test-retest 
reliability correlations of .85 indicating very high internal stability (Fischer & 
Corcoran, 1994). The scale produces scores from 10-40 with higher scores indicating 
greater self-esteem. Scores were divided into 3 categories: 10-20 (low); 21-30 
(medium); and 31-40 (high). Items in the scale include; “I feel that I have a number of 
good qualities”, “I take a positive attitude towards myself”, and “I feel that I’m a 
person of worth, at least on an equal plane with others”. 
 
Depression  
• The Centre for Epidemiological Studies Depression Scale (CES-D) (Radloff, 
1977) 
The CES-D is a 20-item scale designed to measure depression in the general 
population. However, it has also been used with clinical and psychiatric populations. 
The instrument is easily used, extensively researched and has broad applicability. The 
CES-D has excellent concurrent validity and correlates well with a range of other 
depression and mood scales. It has good known-groups validity and discriminates 
well between psychiatric inpatients and the general population, and moderately well 
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between levels of severity within patient groups. The CES-D has good internal 
consistency with alphas of .85 in the general population and .90 in the psychiatric 
population. The CES-D also has acceptable test-retest correlations ranging from .51 to 
.67 (tested from two to eight weeks). This measure has also been shown to be 
sensitive to measuring change in psychiatric status after treatment (Fisher & 
Corcoran, 1994). Items in the CES-D include; “I was bothered by things that usually 
don’t bother me”, “I had trouble keeping my mind on what I was doing”, “I felt that 
everything I did was an effort”, and “I felt depressed”. 
 
The CES-D produces scores ranging from 0-60, with scores above 16 indicative of 
depressed mood, and scores above 26 indicative of major depression (Ensel, 1986; 
Zich & Attkinson, 1990). Depression categories used for this analysis were: 0-15 
(Normal); 16-26 (indicative of Mild Depression); 27-60 (indicative of Major 
Depression). 
 
Anxiety  
• Mind Over Mood Anxiety (MOM-A) Inventory ( Greenberger & Padesky, 1995) 
This scale was recommended for use with substance abuse treatment populations by 
Marsh and Dale (2000) and has been used by several AOD treatment services in 
Western Australia. Little research has been published on this inventory although Cox, 
Beal, and Brittain (2005) report results of a concurrent validity study comparing the 
Mind over Mood Inventory with the Beck Anxiety Inventory (BAI) and the Burns 
Anxiety Inventory (Burn’s-A) with a group of 100 undergraduate students. Cox et al. 
state that the MOM-A correlation with the Burn’s-A was 0.849, (p <.01), and the 
correlation with BAI was 0.724 with the Beck Anxiety Inventory.  
 
The Mind Over Mood Anxiety instrument presented difficulties in determining 
commonly accepted categories of anxiety scores because this instrument has not been 
cited in previous research. The 24 item measure produces scores from 0-72, and in the 
absence of suggested categorical scoring for this instrument, the scores were divided 
into three approximately equal categories using a method described by Keller, (2005): 
Class width = (maximum score – minimum score/ number of classes). This method 
resulted in 3 anxiety classifications: 0-24 (low anxiety), 25-48 (medium anxiety), and 
49-72 (high anxiety). The instrument asks respondents to rate how much they have 
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experienced symptoms in the previous week, and test items include; “Feeling 
nervous”, “Sweating not due to the heat”, “Avoiding places where I might feel 
anxious”, and “Rapid heartbeat”. 
 
Psychoactive Medication Use 
Prescribed client psychoactive medications included anti-depressant 
medication (primarily Selective Serotonin Re-uptake Inhibitor type, or SSRI), anti-
psychotic medications, and mood stabiliser medications. The large majority of 
prescribed client medications were the SSRI anti-depressant class of medication, with 
smaller numbers of clients prescribed various mood stabiliser and anti-psychotic 
medications. At entry there were 151 clients not taking medications, 67 clients taking 
anti-depressants, 12 clients prescribed anti-psychotics, and 4 clients prescribed mood 
stabilising medications. A small number of clients had also been prescribed 
Naltrexone; however this was not recorded in the database. The small number of 
clients prescribed medications other than anti-depressants did not allow their separate 
analysis effect on client treatment retention. Client use of any medication was 
therefore collapsed into a single Medication Use variable, with two levels, 
“Medication Use” or “No Medication Use”. 
 
Primary Drug of Abuse 
On treatment entry clients are asked to name their current primary drug of use, 
resulting in four primary drug categories comprising amphetamines (principally 
methamphetamine, however the two terms are used inter-changeably throughout this 
paper), alcohol, opiates and cannabis. It should be noted that, from the year 2000, 
there was a reduction in the local availability of opiates (heroin) in Western Australia, 
and a sharp and sustained increase in the availability and illicit use of 
methamphetamines. The change in patterns of primary drug of abuse from opiates and 
alcohol to methamphetamines presented major challenges for most Western 
Australian AOD residential treatment services at that time. The methamphetamine-
using population were usually younger males who were commonly presenting to 
AOD treatment services with a range of mental health problems. This population soon 
became the major client group in most Western Australian treatment services during 
those years. It should be noted that Methamphetamines are primarily labelled as 
Amphetamines in most of the frequency and analysis tables within the results section. 
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Stage 1 Procedure 
 
Written permission was obtained from the AOD Agency to assess and analyse 
the residential treatment facility’s client database from the 2000-2005 period (see 
Appendix D). The researcher was provided with an electronic copy of the database 
that was copied to the researcher’s private computer. This data file was password 
protected on the researcher’s private computer. The database contains non-identifiable 
client data and corresponding psychological test scores collected as standard clinical 
practice during that period of operation. The psychometric data collection points of 
the residential service occurred at program entry, then 2, 8 and 14 weeks after entry. 
For the purpose of this analysis, and to allow comparisons with past research findings, 
the 8 and 14 week points in the treatment program were chosen as the times to 
measure client treatment retention. Analysis of the data using a statistical package 
(Statistical Package for the Social Sciences, SPSS, Version 19) identified variables 
indicating a significant association with retention and attrition risk at the 8 and 14-
week stages of treatment. 
Analysis of 14-week retention in treatment was chosen for the purpose of 
exploring the 3-month period of treatment that previous research analysing AOD 
treatment retention and longer-term outcomes had stated was significant (Simpson, 
Joe, Broome, Hiller, Knight, & Rowan-Szal, 1997). Other research analysing 
retention rates in residential programmes have used similar 90 day retention periods, 
(Baker, Gowing, Lee, & Proudfooot, 2004; Brunette, Mueser, & Drake, 2004).  
The 8-week time period in this research was chosen by agency clinicians to 
help discriminate substance–induced elevated psychiatric symptoms from elevated 
symptoms attributed to distinct mental health disorders. Gossop, Marsden, and 
Stewart (2006) noted that many clients entering substance abuse treatment have 
psychiatric symptoms that significantly decrease usually within the first month of 
abstinence. Senior clinicians of the T.C. service also believed that methamphetamine 
withdrawal was more complicated in some individuals, and suspected that 
improvement in psychiatric symptoms could continue over an extended period of up 
to 8 weeks.  
The psychopathology data were also collected at 2 weeks; however the 
archived client data indicated that only nine clients left treatment during the first two 
weeks. The agency clinical staff believed this comparatively small number of client 
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dropouts in the initial two-week period was a reflection of the agency’s stringent entry 
conditions to the TC.  Client entry to this TC involved continuous proof of abstinence 
in the two weeks immediately prior to entry as determined by at least twice weekly 
outpatient urinalysis. The residential service clinical staff believed this period of pre-
entry abstinence provided a significant motivational “test” to help avoid early client 
attrition. This pre-admission period was also believed to help protect existing clients 
from new arrivals who can subsequently leave on impulse soon after arrival. The 2-
week pre-admission procedure also protected the agency from medical complications 
in the event of complicated substance abuse withdrawal, as the service is located in a 
rural area and is unable to easily obtain medical assistance on site.  
It was decided that this small number of clients (nine clients) leaving treatment 
during the initial 2-week period provided insufficient change in retention numbers to 
offer any meaningful results of possible effects of the various independent variables. 
Data from the 2-week period following entry were therefore not analysed. 
 
Stage 1 Data Analysis 
The first stage of data analysis involved use of Binary Logistic Regression 
using SPSS (Statistical Package for the Social Sciences, Version 19). Binary logistic 
regression analysis is a useful statistical method when there is a dichotomous 
dependant variable (e.g., treatment retention or attrition), and allows the relative 
contributions of multiple independent variables (e.g., gender, primary drug, age, 
psychoactive medication use, psychological test scores) to be determined (Cizek & 
Fitzgerald, 1999) and expressed as an odds ratio (OR).  
 
Stage 1 Independent Variables 
Independent variables in the analysis include age, gender, primary drug of 
abuse, use of prescribed psychoactive medications, and measures of anxiety, 
depression and self-esteem. All continuous variables (e.g. age, and the anxiety, 
depression and self-esteem measures), were converted into approximately equal 
categories to better enable interpretation and use of the results in stage 2 of the study.  
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Stage 1 Results 
The sample of 234 clients was comprised of 150 males and 84 females at program 
entry. By 2 weeks, the sample was reduced to 143 males and 82 females, or 96.1% of 
the original sample. By 8 weeks the sample had further reduced to 104 males and 59 
females, or 69.6% of the original sample. At 14 weeks, 67 males and 33 females, or 
42.7% of the original sample remained in the program.  
 
Table 1 
Independent variable frequencies at specific program times 
Independent  
Variables  
Number at  
Entry 
Number at 
 2 weeks 
Number at 
 8 weeks 
Number at 
 14 weeks 
Gender     
Male 150 143 104 67 
Female 84 82 59 33 
Age Group     
 (18 – 24) 77 76 46 30 
(25 – 29) 80 74 60 29 
(30 – 50) 77 75 57 41 
Primary Drug     
Amphetamines 132 128 89 56 
Opiates 31 29 21 9 
Alcohol 44 43 33 23 
Cannabis 27 25 20 12 
Medication     
Anti-depressant 67 67 49 25 
Anti-psychotic 12 12 9 4 
Other 4 4 2 1 
All Medication: 83 83 60 30 
No medication 151 142 103 70 
Depression level     
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Low (0 – 15) 43 49 72 57 
Medium (16 – 26) 61 88 68 34 
High (27 – 60) 130 88 23 9 
Anxiety Level     
Low (0 – 24) 86 124 132 86 
Medium (25 – 48) 134 99 30 14 
High (49 – 72) 14 2 1 0 
 
Self-Esteem Level  
    
Low ( 10 – 20) 2 0 0 0 
Medium (21 – 30) 153 113 38 12 
High (31 – 40) 79 112 125 88 
 
Totals 
 
234 
 
225 
 
163 
 
100 
 
Table 1 summarises frequency change of the independent variables over time, and 
indicates that rates of attrition are reasonably similar within gender, age and the 
primary drug categories. 
 
The following tables Nos. 2 to 13 are cross-tabulations of several of the independent 
variables that have been included to better describe data frequencies between some of 
the variables, and changes of key variable frequencies (depression levels) over time.  
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Table 2 
Client Gender X Age Group at Program Entry 
 Age group  
 17-23 24-29 30-50 Total 
     
 Male Count 48 56 46 150 
% within Client Gender 32.0% 37.3% 30.7% 100.0% 
% within Age group 62.3% 70.0% 59.7% 64.1% 
       
Female Count 29 24 31 84 
% within Client Gender 34.5% 28.6% 36.9% 100.0% 
% within Age group 37.7% 30.0% 40.3% 35.9% 
       
Total Count 77 80 77 234 
% within Client Gender 32.9% 34.2% 32.9% 100.0% 
% within Age group 100.0% 100.0% 100.0% 100.0% 
 
Table 2 provides the number and percentage of males in females at entry according to 
the three age groupings and indicates that the age group distributions of male and 
female clients were similar. 
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Table 3 
Primary Drug of Abuse X Age Group 
 Age group Total 
17-23 24-29 30-50 
  
Amphetamines 
 
Count 
 
51 
 
50 
 
31 
 
132 
% within Primary Drug  38.6% 37.9% 23.5% 100.0% 
% within Age group 66.2% 62.5% 40.3% 56.4% 
 
Opiates 
 
Count 
 
8 
 
13 
 
10 
 
31 
% within Primary Drug  25.8% 41.9% 32.3% 100.0% 
% within Age group 10.4% 16.3% 13.0% 13.2% 
 
Alcohol 
 
Count 
 
5 
 
10 
 
29 
 
44 
% within Primary Drug  11.4% 22.7% 65.9% 100.0% 
% within Age group 6.5% 12.5% 37.7% 18.8% 
 
Cannabis 
 
Count 
 
13 
 
7 
 
7 
 
27 
% within Primary Drug  48.1% 25.9% 25.9% 100.0% 
% within Age group 16.9% 8.8% 9.1% 11.5% 
      
Total Count 77 80 77 234 
% within Primary Drug  32.9% 34.2% 32.9% 100.0% 
% within Age group 100.0% 100.0% 100.0% 100.0% 
 
Table 3 shows the age groupings of the entire sample at entry according to primary 
drug of abuse. In this table it can be seen that primary drug of abuse was associated 
with age, and that amphetamines/methamphetamines were nominated as the primary 
drug of abuse by 66.2% of the 17 – 23 year old group, 62.5% of the 24-29 year old 
group, and 40.3% of the 30-50 year old group. The large majority (65.9%) of persons 
nominating alcohol as their primary drug were in the older age group, and 48.1% of 
persons nominating cannabis as their primary drug were in the youngest group. 
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Table 4 
Medication Use X Age Group 
 Age group  
Total 17-23 24-29 30-50 
  
No Medication 
 
Count 
 
48 
 
51 
 
52 
 
151 
% within  
+ or - Medication 
31.8% 33.8% 34.4% 100.0% 
% within Age group 62.3% 63.7% 67.5% 64.5% 
       
Any Medication Count 29 29 25 83 
% within  
+ or - Medication 
34.9% 34.9% 30.1% 100.0% 
% within Age group 37.7% 36.3% 32.5% 35.5% 
 
Total 
 
Count 
 
77 
 
80 
 
77 
 
234 
% within  
+ or - Medication 
32.9% 34.2% 32.9% 100.0% 
% within Age group 100.0% 100.0% 100.0% 100.0% 
 
Table 4 shows the three age groupings of the sample at entry according to medication 
use and indicates that medication use at program entry was unrelated to age of client. 
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Table 5 
Client Gender X Depression Level at Entry 
 Depression level at Entry  
Total Low  
(0 - 15) 
Medium 
(16 - 26) 
High  
(27 - 60) 
  
Male 
 
Count 
 
32 
 
45 
 
73 
 
150 
% within Client Gender 21.3% 30.0% 48.7% 100.0% 
% within Depression level 74.4% 73.8% 56.2% 64.1% 
 
Female 
 
Count 
 
11 
 
16 
 
57 
 
84 
% within Client Gender 13.1% 19.0% 67.9% 100.0% 
% within Depression level 25.6% 26.2% 43.8% 35.9% 
 
Total 
 
Count 
 
43 
 
61 
 
130 
 
234 
% within Client Gender 18.4% 26.1% 55.6% 100.0% 
% within Depression level  100.0% 100.0% 100.0% 100.0% 
 
Table 5 shows depression levels at program entry for male and female clients, with a 
greater percentage of females (67.9%) reporting high levels of depression at entry, 
compared to males (48.7%). 
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Table 6 
Client Gender X Anxiety Level at Entry 
 Anxiety Level at Entry  
Total Low  
(0 - 24) 
Medium  
(25- 48) 
High  
(49- 72) 
 Male Count 65 77 8 150 
% within Client Gender 43.3% 51.3% 5.3% 100.0% 
% within Anxiety Level  75.6% 57.5% 57.1% 64.1% 
Female Count 21 57 6 84 
% within Client Gender 25.0% 67.9% 7.1% 100.0% 
% within Anxiety Level  24.4% 42.5% 42.9% 35.9% 
Total Count 86 134 14 234 
% within Client Gender 36.8% 57.3% 6.0% 100.0% 
% within Anxiety Level  100.0% 100.0% 100.0% 100.0% 
 
Table 6 shows anxiety levels at program entry and indicates that both males and 
females primarily reported low to medium levels of anxiety at entry, with a higher 
percentage of males reporting low anxiety levels compared with females.   
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Table 7 
Client Gender X Self-Esteem Level at Entry 
 Self-Esteem Level at Entry  
Total Low  
(10 - 20) 
Medium 
(21 - 30) 
High  
(31 - 40) 
 Male Count 2 94 54 150 
% within Gender 1.3% 62.7% 36.0% 100.0% 
% within Self-
Esteem Level  
100.0% 61.4% 68.4% 64.1% 
Female Count 0 59 25 84 
% within Gender .0% 70.2% 29.8% 100.0% 
% within Self-
Esteem Level  
.0% 38.6% 31.6% 35.9% 
Total Count 2 153 79 234 
% within Gender .9% 65.4% 33.8% 100.0% 
% within Self-
Esteem Level  
100.0% 100.0% 100.0% 100.0% 
 
Table 7 shows self-esteem levels for male and female clients at program entry and 
indicates that the large majority of clients enter the program with medium levels of 
self-esteem (62.7 % of males, and 70.2% of females). 
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Table 8 
Primary Drug of Abuse X Client Gender 
   
Total Male Female 
 Amphetamines  85 47 132 
 56.7% 56.0% 56.4% 
Opiates  20 11 31 
 13.3% 13.1% 13.2% 
Alcohol  23 21 44 
 15.3% 25.0% 18.8% 
Cannabis  22 5 27 
 14.7% 6.0% 11.5% 
                       Total  150 84 234 
 100.0% 100.0% 100.0% 
 
Table 8 indicates that the majority of both male (56.7%) and female (56.0%) clients 
noted amphetamines/methamphetamines as their primary drug of abuse. Remaining 
males nominated cannabis (14.7%), opiates (13.3%), and alcohol use (15.3%) as their 
principal drugs of abuse; and the remaining females nominated cannabis (6.0%), 
opiates (13.1%) and alcohol (25.0%) as their principle drugs of abuse.  
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Table 9 
Client Gender X Psychoactive Medication Type 
 No Medication Anti-
Depressants 
Anti-
Psychotics 
Other 
Medication 
Total 
 Male 104 
(69.3% of males) 
34 
(22.7%) 
9 
(6.0%) 
3 
(2.0%) 
150 
(100%) 
Female 47 
(55.9% of females) 
33 
(39.3%) 
3 
(3.6%) 
1 
(1.2%) 
84 
(100%) 
            
Total          
151 
(64.5% of clients) 
67 
(28.6%) 
 
12 
(5.1%) 
4 
(1.7%) 
234 
(100%) 
 
Table 9 indicates more males (69.3 %) than females (55.9 %) were not prescribed 
medications. A higher proportion of females (39.3 %) compared to males (22.7 %) 
were prescribed anti-depressant medications. A higher proportion of males (6.0 %) 
were prescribed anti-psychotic medication compared to females (3.6%). 
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Table 10 
Depression Level at Entry X Medication Use 
 Depression level at Entry Total 
Low  
(0 - 15) 
Medium  
(16 - 26) 
High  
(27 - 60) 
 No Medication Count 36 39 76 151 
% No Medication 23.8% 25.8% 50.3% 100.0% 
% Depression level at Entry 83.7% 63.9% 58.5% 64.5% 
Any 
Medication 
Count 7 22 54 83 
% With Medication 8.4% 26.5% 65.1% 100.0% 
% Depression level at Entry 16.3% 36.1% 41.5% 35.5% 
Total Count 43 61 130 234 
% within + or - Medication 18.4% 26.1% 55.6% 100.0% 
% Depression level at Entry 100.0% 100.0% 100.0% 100.0% 
 
Table 10 indicates the majority of clients prescribed medications scored in the high 
depression level at program entry (65.1% of all medicating clients), and medium 
depression level at entry (26.5% of all medicating clients). It should also be noticed 
that 50.3% of the clients taking no medications scored in the high level of depression 
at entry, and 25.8% scored in the medium level of depression. 
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Table 11 
Depression Level at 2 Weeks X Medication Use 
 Depression level at 2 Weeks Total 
Low  
(0 - 15) 
Medium 
(16 - 26) 
High  
(27 - 60) 
 No 
Medication 
Count 40 56 46 142 
% No Medication 28.2% 39.4% 32.4% 100.0% 
% Depression level at 2 Weeks 81.6% 63.6% 52.3% 63.1% 
Any 
Medication 
Count 9 32 42 83 
% With Medication 10.8% 38.6% 50.6% 100.0% 
% Depression level at 2 Weeks 18.4% 36.4% 47.7% 36.9% 
 
Total 
Count 49 88 88 225 
% within + or - Medication 21.8% 39.1% 39.1% 100.0% 
% within Depression level at 2 
Weeks 
100.0% 100.0% 100.0% 100.0% 
 
Table 11 indicates that there was a general decrease in the number of persons in the 
high levels of depression to the medium and low levels of depression for both the 
medicating and non-medicating clients at 2 weeks compared to the numbers of person 
in high depression levels at entry (Table 10). 
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Table 12 
Depression Level at 8 Weeks X Medication Use 
 Depression level at 8 Weeks Total 
Low  
(0 - 15) 
Medium  
(16 - 26) 
High  
(27 - 60) 
 No Medication Count 53 39 11 103 
% No Medication 51.5% 37.9% 10.7% 100.0% 
% Depression level at 8 Weeks 73.6% 57.4% 47.8% 63.2% 
Any 
Medication 
Count 19 29 12 60 
% With Medication 31.7% 48.3% 20.0% 100.0% 
% Depression level at 8 Weeks 26.4% 42.6% 52.2% 36.8% 
Total Count 72 68 23 163 
% + or - Medication 44.2% 41.7% 14.1% 100.0% 
% Depression level at 8 Weeks 100.0% 100.0% 100.0% 100.0% 
 
Table 12 indicates decreasing numbers and percentages of clients remaining with high 
levels of depression at 8 weeks within both medication and non-medication groups.  
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Table 13 
Anxiety Level at Entry X Medication Use 
 
Entry Anxiety level 
  
Total No 
Medication 
Any 
Medication 
 low (0 - 24) Count 60 26 86 
% within + or - 
Medication 
39.7% 31.3% 36.8% 
Medium (25- 48) Count 81 53 134 
% within + or - 
Medication 
53.6% 63.9% 57.3% 
High (49- 72) Count 10 4 14 
% within + or - 
Medication 
6.6% 4.8% 6.0% 
Total Count 151 83 234 
% within + or - 
Medication 
100.0% 100.0% 100.0% 
 
Table 13 indicates a lower percentage of medicating clients in the low anxiety level 
group (31.3%), compared to non-medicating clients at entry (39.7%). There was a 
higher percentage of medicating clients in the medium anxiety level (63.9%) group 
compared to the non-medicating clients (53.6%). 
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Table 14 
Primary Drug of Abuse X Psychiatric Medication Type 
 No 
Medication 
Anti- 
Depressant 
Anti- 
Psychotic 
Other  
Medication 
 
Total 
 Amphetamines Count 91 36 5 0 132 
% within 
Medication 
60.3% 53.7% 41.7% .0% 56.4% 
Opiates Count 22 7 0 2 31 
% within 
Medication 
14.6% 10.4% .0% 50.0% 13.2% 
Alcohol Count 23 19 0 2 44 
% within 
Medication 
15.2% 28.4% .0% 50.0% 18.8% 
Cannabis Count 15 5 7 0 27 
% within 
Medication 
9.9% 7.5% 58.3% .0% 11.5% 
Total Count 151 67 12 4 234 
% within 
Medication 
100.0% 100.0% 100.0% 100.0% 100.0% 
 
Table 14 indicates the breakdown of medication type by primary drug of use, and 
reveals that anti-psychotic medication was prescribed to clients who had reported that 
either methamphetamines, or cannabis as their primary drug problem. Anti-depressant 
medication was the most common medication, and had been prescribed to: 36 (27.3%) 
of methamphetamine users, 7 (22.5%) of opioid users, 19 (43.2%) of alcohol users, 
and to 5 (18.5%) cannabis users. “Other medications” were comprised of Naltrexone 
that had also been prescribed to two opioid users, and mood stabilising medications 
had been prescribed to 2 alcohol users.  
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Prediction of retention at 8 weeks: 
The primary questions posed in stage 1 of this thesis concerned prediction of retention 
in the program at eight and fourteen weeks. By eight weeks, of the original 234 clients 
(150 males and 84 females) only 163 (69.7%) remained (104 males and 59 females). 
In this initial set of 7 analyses, the variables of gender, age, drug of abuse, use of 
medication, level of anxiety, depression and self-esteem assessed on entry into the 
program were progressively entered into a series of binary logistic regression 
equations predicting retention as a method of preliminary exploration of the data. 
Significant results (p < .05) are identified in bold type within the tables. 
 
Table 15 
Analysis No. 1 for Gender Predicting Retention at 8 Weeks  
Step 1a p Exp(B) 95% C.I. for Exp(B) 
Gender .885 0.958 0.535 1.715 
Constant .000 2.360   
 
Gender was not a significant predictor of retention at 8 weeks. 
 
 
Table 16 
Analysis No. 2 for Gender and Age Group Predicting Retention at 8 Weeks  
Step 1a p Exp(B) 95% C.I. for Exp(B) 
Gender(1) .821 0.934 0.518 1.685 
Age group 
(18 – 24 years)  
.128    
Age group (1) 
(25 – 29 years) 
.126 0.588 0.298 1.161 
Age group (2) 
(30 – 50 years)  
.732 1.133 0.554 2.316 
Constant .001 2.778   
 
Age group and gender in the equation were not significant predictors of 8 week 
retention. 
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Table 17 
Analysis No. 3 for Gender, Age Group and Primary Drug Predicting Retention at 8 
Weeks   
Step 1a p Exp(B) 95% C.I. for Exp(B) 
Gender(1) .738 0.903 0.496 1.643 
Age Group .128    
Age Group(1) .181 0.609 0.295 1.259 
Age Group(2) .594 1.224 0.582 2.573 
Drug 
(Amphetamines) 
.563    
Drug(1) 
(Opiates) 
.195 0.518 0.191 1.400 
Drug(2) 
(alcohol) 
.266 0.505 0.151 1.685 
Drug(3) 
(Cannabis) 
.539 0.687 0.208 2.272 
Constant .009 4.700   
 
Gender, age group and primary drug type were not significant predictors of 8 week 
retention. 
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Table 18 
Analysis No. 4 for Gender, Age Group, Primary Drug Type and Medication Use 
Predicting Retention at 8 Weeks  
Step 1a p Exp(B) 95% C.I. for Exp(B) 
 
Gender(1) .822 0.933 0.510 1.708 
Age Group .122    
Age Group(1) .161 0.594 0.286 1.231 
Age Group(2) .639 1.195 0.567 2.519 
Drug .636    
Drug(1) .225 0.539 0.198 1.464 
Drug(2) .299 0.527 0.157 1.766 
Drug(3) .532 0.683 0.207 2.257 
Medication(1) 
(Any medication) 
.432 0.781 0.421 1.447 
Constant .006 5.358   
 
Medication use was not a significant predictor of 8 week retention when gender, age 
and primary drug were also included in the model. 
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Table 19 
Analysis No. 5 for Gender, Age Group, Primary Drug Type, Medication Use and 
Anxiety Levels at Entry Predicting Retention at 8 Weeks  
Step 1a p 
Exp(B) 
95% C.I. for Exp(B) 
 
Gender(1) .865 0.947 0.503 1.783 
Age Group .127    
Age Group(1) .188 0.602 0.283 1.282 
Age Group(2) .550 1.261 0.590 2.697 
Drug .633    
Drug(1) .248 0.549 0.199 1.517 
Drug(2) .318 0.531 0.154 1.836 
Drug(3) .637 0.743 0.217 2.547 
Medication Group(1) .562 0.828 0.439 1.565 
Anx Lev Ent .006    
Anx Lev Ent(1) 
(Medium anxiety) 
.012 5.313 1.446 19.524 
Anx Lev Ent(2) 
(High anxiety) 
.002 7.572 2.141 26.775 
Constant .841 0.839   
 
Medium and high anxiety levels were significant predictors of 8 week retention when 
gender, age group, primary drug and medication use were also included in the 
equation. The medium level of anxiety at entry was significant (OR = 5.313, 95% C.I 
= 1.446/19.524, p = .012). The high level of anxiety was also significant (OR = 7.572, 
95% C.I. = 2.141/26.775, p = .002), indicating that the groups with medium or high 
level of anxiety at entry were significantly more likely to be retained at 8 weeks.  
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Table 20 
Analysis No. 6 for Gender, Age Group, Primary Drug Type, Medication, Anxiety and 
Depression Levels at Entry Predicting Retention at 8 Weeks  
Step 1a p Exp(B) 95% C.I. for Exp(B) 
 
Gender(1) .632 0.854 0.446 1.632 
Age Group .088    
Age Group(1) .149 0.564 0.259 1.228 
Age Group(2) .519 1.290 0.595 2.796 
Drug .659    
Drug(1) .244 0.539 0.190 1.526 
Drug(2) .308 0.513 0.142 1.849 
Drug(3) .559 0.687 0.195 2.423 
Medication Group(1) .660 0.862 0.446 1.667 
AnxLevEnt .011    
AnxLevEnt(1) 
(Medium Anxiety) 
.034 4.628 1.121 19.102 
AnxLevEnt(2) 
(High Anxiety) 
.003 6.680 1.880 23.735 
DepLevEnt .032    
DepLevEnt(1) 
(Med Depression) 
.790 0.879 0.340 2.270 
DepLevEnt(2) 
(High Depression) 
.021 2.719 1.162 6.362 
Constant .857 0.852   
 
With the addition of depression levels into the previous equation, the medium level of 
anxiety at entry was significant (OR = 4.628, 95% C.I. = 1.121/19.102, p = .034), and 
high levels of anxiety at entry was significant (OR = 6.680, 95% C.I. = 1.880/23.735, 
p = .003). The high level of depression at entry was also significant (OR = 2.719, 95% 
C.I. = 1.162/6.362, p = .021). Clients with medium and high levels of anxiety at entry, 
and high level of depression at entry were significantly more likely retained at 8 
weeks. 
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Table 21 
Analysis No. 7 for Gender, Age Group, Primary Drug Type, Medication, Anxiety, 
Depression and Self-Esteem Levels at Entry Predicting Retention at 8 Weeks  
Step 1a p Exp(B) 95% C.I. for Exp(B) 
 
Gender(1) .610 0.844 0.439 1.623 
Age Group .063    
Age Group(1) .166 0.574 0.261 1.259 
Age Group(2) .377 1.429 0.647 3.160 
Drug .635    
Drug(1) .225 0.516 0.177 1.503 
Drug(2) .289 0.492 0.133 1.824 
Drug(3) .528 0.664 0.186 2.371 
MedicationGroup(1) .765 0.903 0.465 1.756 
AnxLevEnt .019    
AnxLevEnt(1) .059 4.034 0.948 17.163 
AnxLevEnt(2) .006 6.024 1.659 21.871 
DepLevEnt .018    
DepLevEnt(1) .675 1.251 0.440 3.561 
DepLevEnt(2) .008 3.517 1.398 8.852 
SELevEnt .240    
SELevEnt(1) 
(Med Self-esteem) 
1.000 0.999 0.047 21.460 
SELevEnt(2) 
(High Self-esteem) 
.096 1.870 0.894 3.910 
Constant .531 0.549   
 
Self-esteem level at entry did not predict retention at 8 weeks when added to the other 
variables in the equation. The high level of anxiety at entry was significant (OR = 
6.024, 95% C.I. = 1.659/21.871, p = .006). The high level of depression at entry was 
also significant (OR = 3.517, 95% C.I. = 1.398/8.852, p = .008). The groups with high 
level of anxiety of depression were more likely retained in treatment at 8 weeks. 
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Table 22 
Analysis No. 8 for Gender, Age Group, Primary Drug Type, Medication, Anxiety, 
Depression and Self-Esteem Levels at 2 Weeks Predicting Retention at 8 Weeks  
Step 1a p Exp(B) 95% C.I. for Exp(B) 
 
Gender(1) .705 0.881 0.456 1.700 
MedicationGroup(1) .979 0.991 0.513 1.916 
Age Group .039    
Age Group(1) .141 0.558 0.257 1.213 
Age Group(2) .349 1.489 0.647 3.424 
Drug .274    
Drug(1) .054 0.311 0.095 1.022 
Drug(2) .177 0.380 0.093 1.550 
Drug(3) .224 0.426 0.108 1.687 
AnxLev2 .619    
AnxLev2(1) .999 0.000 0.000 . 
AnxLev2(2) .999 0.000 0.000 . 
DepLev2 .875    
DepLev2(1) .983 0.988 0.333 2.930 
DepLev2(2) .664 0.843 0.391 1.817 
SELev2(1) .522 1.238 0.643 2.385 
Constant .999 3.200   
 
None of the variables including anxiety, depression or self-esteem levels at 2 weeks 
predicted retention at 8 weeks. 
 
The following set of analyses (Tables 16 to 22) involved the progressive addition of 
variables into equations looking for significant predictors of retention at 14 weeks. 
The anxiety, depression and self-esteem scores were program entry scores. 
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Table 23 
Analysis No. 9 for Gender Predicting Retention at 14 Weeks  
Step 1a p Exp(B) 95% C.I. for Exp(B) 
Gender(1) .425 1.248 0.724 2.148 
Constant .051 0.647   
 
Gender did not predict retention at 14 weeks 
 
Table 24 
Analysis No. 10 for Gender and Age Group Predicting Retention at 14 Weeks  
Step 1a p Exp(B) 95% C.I. for Exp(B) 
Gender(1) .328 1.318 0.758 2.293 
Age group .062    
Age group (1) .072 0.555 0.292 1.055 
Age group (2) 
(30-50 years) 
.027 0.484 0.254 0.921 
Constant .903 0.966   
 
The addition of age group to the equation indicated that the oldest age group (30-50 
years) was significantly more likely to drop out of the program prior to 14 weeks (OR 
= .484, 95% C.I. = .254/.921, p = .027). 
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Table 25 
Analysis No. 11 for Gender, Age Group and Primary Drug Predicting Retention at 14 
Weeks  
Step 1a p Exp(B) 95% C.I. for Exp(B) 
Gender(1) .328 1.318 0.758 2.293 
Age Group .062    
Age Group(1) .072 0.555 0.292 1.055 
Age Group(2) 
(30-50 years) 
.027 0.484 0.254 0.921 
Drug .903 0.966   
Drug(1) .328 1.318 0.758 2.293 
Drug(2) .062    
Drug(3) .072 0.555 0.292 1.055 
Constant .027 0.484 0.254 0.921 
 
The addition of primary drug to the equation showed that the oldest age group (30-50 
years) were significantly more likely to drop out prior to 14 weeks (OR = .484, 95% 
C.I. = .254/.921, p = .027). 
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Table 26 
Analysis No. 12 for Gender, Age Group, Primary Drug Type and Medication 
Predicting Retention at 14 Weeks  
Step 1a p Exp(B) 95% C.I. for Exp(B) 
Gender(1) .415 1.268 .716 2.245 
Age Group .161    
Age Group(1) .147 0.599 0.300 1.197 
Age Group(2) .068 0.533 0.271 1.048 
Drug .340    
Drug(1) .858 0.924 0.391 2.185 
Drug(2) .202 0.483 0.158 1.475 
Drug(3) .708 1.217 0.436 3.396 
Medication(1) 
(Any meds) 
.137 1.548 0.870 2.753 
Constant .633 0.775   
 
The addition of medication to the equation resulted in none of the variables predicting 
retention at 14 weeks. 
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Table 27 
Analysis No. 13 for Gender, Age Group, Primary Drug Type, Medication and Anxiety 
Level at Entry Predicting Retention at 14 Weeks  
Step 1a p Exp(B) 95% C.I. for Exp(B) 
Gender(1) .448 1.253 .700 2.243 
Age Group .189    
Age Group(1) .184 .621 .308 1.254 
Age Group(2) .078 .541 .273 1.071 
Drug .324    
Drug(1) .880 .936 .394 2.224 
Drug(2) .220 .495 .161 1.521 
Drug(3) .626 1.296 .458 3.671 
MedicationGroup(1) .115 1.595 .892 2.849 
AnxLevEnt .259    
AnxLevEnt(1) .118 2.993 .758 11.827 
AnxLevEnt(2) .102 3.052 .800 11.642 
Constant .115 .258   
 
The addition of anxiety level to the equation resulted in no variable predicting 
retention at 14 weeks. 
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Table 28 
Analysis No. 14 for Gender, Age Group, Primary Drug Type, Medication, Anxiety 
and Depression Levels at Entry Predicting Retention at 14 Weeks  
Step 1a p Exp(B) 95% C.I. for Exp(B) 
Gender(1) .437 1.262 .701 2.271 
Age Group .199    
Age Group(1) .199 .630 .312 1.275 
Age Group(2) .081 .543 .274 1.079 
Drug .394    
Drug(1) .979 .988 .413 2.365 
Drug(2) .321 .561 .179 1.760 
Drug(3) .540 1.390 .485 3.985 
MedicationGroup(1) .079 1.699 .941 3.066 
AnxLevEnt .188    
AnxLevEnt(1) .069 3.899 .901 16.862 
AnxLevEnt(2) .092 3.190 .828 12.293 
DepLevEnt .463    
DepLevEnt(1) .231 .577 .234 1.420 
DepLevEnt(2) .857 .940 .479 1.843 
Constant .089 .229   
 
The addition of depression level to the equation resulted in no variable predicting 
retention at 14 weeks. 
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Table 29 
Analysis No. 15 for Gender, Age Group, Primary Drug Type, Medication, Anxiety, 
Depression and Self-Esteem Levels at Entry Predicting Retention at 14 Weeks  
Step 1a p Exp(B) 95% C.I. for Exp(B) 
Gender(1) .450 1.257 .694 2.276 
Age Group .291    
Age Group(1) .243 .654 .321 1.334 
Age Group(2) .131 .585 .291 1.174 
Drug .401    
Drug(1) .966 1.019 .422 2.460 
Drug(2) .362 .585 .185 1.853 
Drug(3) .487 1.456 .505 4.203 
MedicationGroup(1) .077 1.709 .944 3.097 
AnxLevEnt .242    
AnxLevEnt(1) .094 3.594 .805 16.050 
AnxLevEnt(2) .118 2.993 .757 11.837 
DepLevEnt .723    
DepLevEnt(1) .709 .829 .310 2.217 
DepLevEnt(2) .652 1.181 .573 2.433 
SELevEnt .166    
SELevEnt(1) .635 2.227 .082 60.495 
SELevEnt(2) .059 1.899 .975 3.699 
Constant .029 .131   
 
The addition of self-esteem level at entry to the equation resulted in no variable 
predicting retention at 14 weeks. 
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Table 30 
Analysis No. 16 for Gender, Age Group, Primary Drug Type, Medication, Anxiety, 
Depression and Self-Esteem Levels at 2 Weeks Predicting Retention at 14 Weeks  
Step 1a p Exp(B) 95% C.I. for Exp(B) 
Gender(1) .369 1.320 0.721 2.419 
Age Group .143    
Age Group(1) .080 0.524 0.255 1.079 
Age Group(2) .088 0.537 0.263 1.097 
Drug .353    
Drug(1) .578 0.771 0.309 1.926 
Drug(2) .137 0.414 0.130 1.324 
Drug(3) .989 1.008 0.342 2.971 
Medication Group(1) .051 1.825 0.996 3.342 
AnxLev2 .592    
AnxLev2(1) .780 0.660 0.036 12.208 
AnxLev2(2) .615 0.476 0.026 8.564 
DepLev2 .437    
DepLev2(1) .244 0.564 0.215 1.480 
DepLev2(2) .828 0.925 0.460 1.860 
SELev2(1) .975 1.010 0.557 1.832 
Constant .709 1.811   
 
The variables of gender, age group, primary drug type, medication, anxiety, 
depression or self-esteem levels at 2 weeks did not predict retention at 14 weeks. 
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Table 31 
Analysis No. 17 for Gender, Age Group, Primary Drug Type, Medication, Anxiety, 
Depression and Self-Esteem Levels at 8 Weeks Predicting Retention at 14 Weeks  
Step 1a p Exp(B) 95% C.I. for Exp(B) 
Gender(1) .296 1.490 0.706 3.146 
Age Group .039    
Age Group(1) .887 0.931 0.344 2.515 
Age Group(2) 
(30-50 years) 
.032 0.388 0.163 0.923 
Drug .281    
Drug(1) .680 1.255 0.426 3.694 
Drug(2) .393 0.557 0.145 2.136 
Drug(3) .373 1.823 0.486 6.828 
Medication Group(1) 
(Any medication) 
.028 2.252 1.094 4.638 
AnxLev2 .511    
AnxLev2(1) 1.000 .000 .000 . 
AnxLev2(2) 1.000 .000 .000 . 
DepLev2 .682    
DepLev2(1) .383 .570 .161 2.014 
DepLev2(2) .515 .672 .203 2.225 
SELev2(1) .993 .996 .384 2.581 
Constant 1.000 7.198E8   
 
The highest age group (30-50 years) was significantly more likely to drop out prior to 
14 weeks (OR = .388, 95% C.I. = .163/.923, p = .032), and the group taking 
medication were more likely retained at 14 weeks (OR = 2.252, 95% C.I. = 
1.094/4.638, p = .028). 
 
Following an analysis of the various category variables, it was decided to adjust two 
of the variables (Primary Drug & Anxiety Level) and re-run the previous analyses 
involving all independent variables predicting retention at 8 weeks and 14 weeks, 
(Analyses 18 – 22). 
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The 2 variables adjusted for Analyses 18 - 22, were: 
1) Primary Drug: Amphetamines =1; Opiates, Alcohol & Cannabis (Depressants) = 2. 
2) Anxiety Level: Low Anxiety (0- 24) = 1; and Medium/High Anxiety (25 – 72) = 2. 
 
Analysis 18 examined variables predicting attrition and retention 8 weeks after 
treatment entry. The Dependent Variable (DV) was retention in treatment at 8 weeks, 
and Independent Variables (IV) were gender, age group, medication use, primary drug 
of abuse; and depression, anxiety and self-esteem levels measured at treatment entry. 
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Table 32 
Analysis No. 18 Retention at 8 Weeks with Entry Level Scores  
Variable OR 95% CI p 
Gender     (males)    
Gender 1  (female)   1.127 .601/2.114 0.709 
Drug         (amphetamines)    
Drug 1    (depressants: opiates, 
alcohol & cannabis) 
0.789 .423/1.471 0.456 
Medication (none)    
Medication 1 (any) 0.832 .437/1.582 0.575 
Age         (17 - 23 years)    
Age 1      (24 -  29 years) 0.583 .280/1.211 0.148 
Age 2      (30 - 50 years) 1.367 .636/2.940 0.424 
Anxiety level (low)    
Anxiety level (medium/high) 0.817 .376/1.774 0.609 
Depression level (low)    
Depression level (medium) 1.284 .465/3.544 0.630 
Depression level (high) 3.725 1.534/9.047 0.004 
Self-Esteem level (low)    
Self-Esteem level (medium)  0.661 .036/12.211 0.781 
Self-Esteem level (high) 1.983 .966/4.070 0.062 
 
There was one significant variable predicting 8 week retention with treatment entry 
depression, anxiety and self-esteem scores. The group with high entry levels of 
depression were 3.725 times more likely retained at 8 weeks; (OR = 3.725, CI = 
1.534/9.047, P = 0.004). 
 
Analysis No. 19 examined variables predicting attrition and retention 8 weeks after 
treatment entry. The Dependent Variable (DV) was retention in treatment at 8 weeks, 
and Independent Variables (IV) were age group, gender, medication use, primary drug 
of abuse; and depression, anxiety and self-esteem levels measured at 2 weeks after 
treatment entry. 
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Table 33 
Analysis No. 19 Retention at 8 Weeks with 2-Week Scores  
Variable OR 95% CI p 
Gender     (males)    
Gender 1  (female)   1.039 0.504/1.982 .908 
Drug         (amphetamines)    
Drug 1    (depressants: opiates, 
alcohol & cannabis) 
0.622 0.326/1.189 .151 
Medication (none)    
Medication 1 (any) 0.936 0.489/1.795 .843 
Age         (17 - 23 years)    
Age 1      (24 -  29 years) 0.620 0.297/1.293 .203 
Age 2      (30 - 50 years) 1.592 0.701/3.614 .266 
Anxiety level (low)    
Anxiety level (medium/high) 1.332 0.626/2.835 .457 
Depression level (low)    
Depression level (medium) 1.055 0.359/3.101 .923 
Depression level (high) 0.874 0.409/1.868 .728 
Self-Esteem level (medium)     
Self-Esteem level (high) 1.290 0.677/2.459 .439 
 
There was no significant variable predicting 8- week retention in the seventh analysis: 
 
Analysis No. 20 examined variables predicting attrition and retention 14 weeks after 
treatment entry. The Dependent Variable (DV) was retention in treatment at 14 
weeks, and Independent Variables (IV) were age group, gender, medication use, 
primary drug of abuse; and depression, anxiety and self-esteem levels measured at 
treatment entry. 
 
 
 
 
 
74 
 
Therapeutic Community Retention 
 
Table 34 
Analysis No. 20 Retention at 14 Weeks with Entry Scores  
Variable OR 95% CI p 
Gender     (males)    
Gender 1  (female)   0.816 0.458/1.455 .491 
Drug         (amphetamines)    
Drug 1    (depressants: opiates, 
alcohol & cannabis) 
1.050 0.595/1.852 .867 
Medication (none)    
Medication 1 (any) 1.571 0.877/2.814 .129 
Age         (17 - 23 years)    
Age 1      (24 -  29 years) 0.573 0.292/1.125 .106 
Age 2      (30 - 50 years) 0.522 0.266/1.024 .059 
Anxiety level (low)    
Anxiety level (medium/high) 1.283 0.642/2.564 .481 
Depression level (low)    
Depression level (medium) 0.833 0.316/2.192 .711 
Depression level (high) 1.262 0.621/2.564 .520 
Self-Esteem level (medium)     
Self-Esteem level (high) 1.967 1.019/3.797 .044 
 
There was one significant variable predicting retention at 14 weeks. The high self-
esteem 2 group were1.967 times more likely retained in treatment at 14 weeks 
compared to the low self-esteem group, (OR = 1.967; 95% CI = 1.019/3.797; P = 
.044). The oldest age group (30-50 years) were less likely retained in treatment at 14 
weeks compared to the youngest group; (OR = 0.522; 95% CI = .266/1.024; P = 
.059), however this result was not significant. 
 
Analysis 21 examined variables predicting attrition and retention 14 weeks after 
treatment entry. The Dependent Variable (DV) was retention in treatment at 14 
weeks, and Independent Variables (IV) were age group, gender, medication use, 
primary drug of abuse; and depression, anxiety and self-esteem levels measured 2 
weeks after treatment entry. 
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Table 35 
Analysis No. 21 Retention at 14 Weeks with 2-Week Scores  
Variable OR 95% CI p 
Gender     (male)    
Gender 1  (female)   0.749 0.416/1.349 0.336 
Drug         (amphetamines)    
Drug 1    (depressants: opiates, 
alcohol & cannabis) 
1.033 0.583/1.832 0.912 
Medication (none)    
Medication 1 (any) 1.673 0.928/3.015 0.087 
Age         (17 - 23 years)    
Age 1      (24 -  29 years) 0.497 0.250/.989 0.047 
Age 2      (30 - 50 years) 0.502 0.251/1.004 0.051 
Anxiety level (low)    
Anxiety level (medium/high) 1.354 0.691/2.653 0.377 
Depression level (low)    
Depression level (medium) 0.591 0.228/1.533 0.280 
Depression level (high) 0.968 0.489/1.917 0.926 
Self-Esteem level (medium)     
Self-Esteem level (high) 1.104 0.617/1.976 0.740 
 
There was one significant variable predicting retention at 14 weeks when including 2 
week depression, anxiety and self-esteem scores. The middle age group (24 – 29 
years) were less likely retained in treatment at 14 weeks compared to the youngest 
group (17-24 years); (OR = 0.497; 95% CI = .250/0.989; P =.047). The oldest age 
group (30 - 50 years) were less likely retained in treatment at 14 weeks compared to 
the youngest group (17-24 years); (OR = 0.502; 95% CI = .251/1.004; P =.051), 
however this result just failed to reach significance. 
 
 
 
 
 
76 
 
Therapeutic Community Retention 
 
Analysis 22 examined variables predicting attrition and retention 14 weeks after 
treatment entry. The Dependent Variable (DV) was retention in treatment at 14 
weeks, and the Independent Variables (IV) were age group, gender, medication use, 
primary drug of abuse; and depression, anxiety and self-esteem levels measured at 8 
weeks after treatment entry. 
 
Table 36 
Analysis No. 22 Retention at 14 Weeks with 8-Week Scores  
Variable OR 95% CI p 
Gender     (males)    
Gender 1  (female)   0.680 0.329/1.402 0.296 
Drug         (amphetamines)    
Drug 1    (depressants: opiates, 
alcohol & cannabis) 
1.221 0.599/2.490 0.583 
Medication (none)    
Medication 1 (any) 2.137 1.054/4.333 0.035 
Age         (17 - 23 years)    
Age 1      (24 -  29 years) 0.716 0.283/1.810 0.480 
Age 2      (30 - 50 years) 0.324 0.283/1.810 0.009 
Anxiety level (low)    
Anxiety level (medium/high) 1.775 0.672/4.688 0.247 
Depression level (low)    
Depression level (medium) 0.611 0.178/2.099 0.434 
Depression level (high) 0.790 0.248/2.516 0.691 
Self-Esteem level (medium)     
Self-Esteem level (high) 1.127 0.444/2.860 0.801 
 
There were two significant variables predicting retention at 14 weeks in this analysis. 
The medication group was 2.317 times more likely retained at 14 weeks than the non-
medication group; (OR = 2.137, 95% CI = 1.054/4.333; P = .035).The oldest age 
group (30-50 years) were less likely retained at 14 weeks compared to the youngest 
group (18 – 24 years); (OR = 0.324; 95% CI = .283/1.810; P = 0.009). 
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Table 37 
Summary of Significant Results:   
(Variables predicting retention & attrition when all variables included in equations)  
 Analysis 
Number 
Significant 
Variables 
P <.05 
Odds
Ratio 
> 1.0 
More 
likely  
Significant 
Variable 
P <.05 
Odds 
Ratio 
< 1.0 
Less 
likely 
8 week Retention 1      
Entry scores 1 7 H Anx (49-72) 
H Dep (27-60) 
6.024 
3.517 
 
Nil 
 
2 Week scores 1 8 Nil  Nil  
      
14 Week Retention 1      
Entry scores 1 15 Nil  Nil  
      
2 week scores 1 16 Nil  Nil  
8 week scores 1 17 Medicating 2.252 Age (30-50) 0.388 
      
2 indicates Analysis 
(# 6 - 10) with 2 
adjusted variables 
Analysis 
# 
Significant 
Variables  
P <.05 
Odds
Ratio 
> 1.0 
More 
likely  
Significant 
Variable  
P <.05 
OddsR
atio 
< 1.0 
Less 
likely 
8 week Retention 2      
Entry scores 2 18 H Dep (27-60) 3.725 Nil  
2 week scores 2 19 Nil  Nil  
14 Week Retention 2      
Entry scores 2 20 S/E (High) 1.967 Nil  
2 week scores 2 21 Nil 
 
 Age (24-29) 
 
0.497 
8 week scores 2 22 Medicating 2.137 Age (30-50) 0.324 
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Summary of Stage 1 Binary Logistic Regression Results 
 
The initial 5 binary logistic regression analyses involving all independent variables 
(analyses Nos. 7, 8, 15, 16 & 17) are discussed first; followed by a discussion of the 
results of the second set of 5 analyses (analyses Nos. 18, 19, 20, 21 & 22) after two of 
the independent variables were adjusted. 
 
Analyses 7 & 8: 
Analysis 7 indicated that 8 week retention was significantly predicted by clients with 
high levels of anxiety and high levels of depression at treatment entry. Interestingly, 
there were no variables predicting attrition by 8 weeks.  
Analysis 8 indicated that no variables, including levels of anxiety, depression and 
self-esteem at 2 weeks were significant for predicting retention or attrition at 8 weeks. 
 
Analyses 15 – 17: 
No variables predicted 14 week retention or attrition when using the anxiety, 
depression and self-esteem level scores at entry (Analysis 15). 
No variables predicted 14 week retention or attrition when using the anxiety, 
depression and self-esteem level scores at 2 weeks (Analysis 16).  
Retention at 14 weeks was predicted by clients taking medication when including the 
8 week anxiety, depression and self-esteem scores (Analysis 17). The oldest group of 
clients (30 – 50 years) were significantly less likely retained at 14 weeks when the 8 
week psychopathology scores were included in the analysis. 
 
 
Analyses 18 – 22: 
Analyses 18 - 22 were undertaken after two independent variables had been adjusted. 
These adjustments involved the collapsing of the initial 4 primary drug categories into 
2 categories; i.e. either depressants (opiates, alcohol and cannabis), or 
amphetamines/methamphetamines. The second adjustment was the collapsing of the 
initial three levels of anxiety scores into two levels only; i.e. low levels of anxiety, or 
medium & high levels of anxiety. 
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Following these two variable adjustments, 8 week retention was only predicted by 
high levels of depression at entry (Analysis 18).  
When measuring depression, anxiety and self-esteem scores at 2 weeks, no variables 
predicted retention or attrition at 8 weeks (Analysis 19). 
14 week retention was predicted by clients with high levels of self-esteem at entry 
(Analysis 20). 
When incorporating the 2 week depression, anxiety and self-esteem scores into the 
equation, no variables predicted 14 week retention, but the middle age group (24 – 29 
years) were significantly less likely retained (Analysis 21).  
When incorporating the 8 week anxiety, depression and self-esteem scores into the 
equation, the medicating clients were significantly more likely retained, and the oldest 
age group were less likely retained in treatment at 14 weeks (Analysis 22). 
 
 
 
Stage 1 Discussion 
  
The significant findings of the stage 1 analyses were as follows. Gender did 
not have a significant influence on treatment retention or attrition at either 8-weeks or 
14-weeks after program entry. Client age group predicted treatment attrition at 14-
weeks, but not in the expected direction of higher levels of attrition with younger 
clients. Elevated depression and anxiety at entry scores predicted 8 week treatment 
retention. Clients prescribed various psychoactive medications for mental health 
problems were more likely to be retained in treatment at 14 weeks. The following 
section will summarise the retention and attrition findings for each of the independent 
variables analysed in the first stage of this study. 
 
Gender and Treatment Entry 
It is also important to note the gender disparity at treatment entry (150 males 
or 64% of total 234 clients at entry, versus 84 females or 36%, representing a ratio of 
male to female clients at entry of 2.8:1).The finding of a greater number of males 
entering the substance abuse treatment program is common, and Greenfield, Brooks, 
Gordon, Green, Kropp, McHugh, Lincoln, Hien & Miele, (2007) report a large review 
of women substance abuse clients in the United States of America (U.S.A.), and note 
that women are much less likely to enter substance abuse treatment services compared 
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to men, hence mixed-gender, U.S.A. substance abuse treatment services almost 
always have less females compared to male clients. This finding of much less women 
entering substance abuse treatment services than males is not limited to U.S.A. 
substance abuse treatment programs. Swift, Copeland & Hall (1996) report an 
analysis of Australian alcohol treatment services, and note that male to female ratios 
of clients in treatment ranged from 3:1 to 10:1. 
The higher ratios of men versus women in substance abuse treatment are 
usually greater in residential services, and many researchers have commented that the 
significantly reduced number of women entering residential treatment services is due 
to family and child-rearing responsibilities of women clients, (Szuster, Rich, Chung & 
Bisconer, 1996). The finding that the proportion of total male and female clients 
entering the TC during the period of data collection was less than 3:1 is interesting 
given that women were unable to enter the treatment program with their children from 
2000, or soon after the initiation of data collection of this present study. Clearly, 
factors other than the ability of women clients to enter treatment with their children 
must account for the fact the program was attracting a relatively high proportion of 
female clients. 
 
Gender and Treatment Retention 
During the period of data collection there were 150 males and 84 females who 
formally entered the program, and 143 males and 82 females remained in the program 
by 2 weeks, representing 95.3 % and 97.6% of the original sample respectively. 
Frequency analyses indicated that 104 males and 59 females were retained in 
treatment at 8 weeks, representing 69.3% and 70.2% of the original sample. When 
measuring retention at 14 weeks, 100 clients (67 males and 33 females) remained in 
treatment, representing 42.7% of the original sample of 234 clients, with 44.7 % of 
the original 150 males, and 39.3% of the original 84 females. There were no 
significant findings for effects of gender on treatment attrition or retention at either 
the 2-week, 8-week or 14-week periods. 
The first important finding of this study relative to gender and retention was 
there were no significant differences between male and female retention rates at either 
8 or 14 weeks after entry. This finding that females were not more likely to drop out 
of treatment may reflect specific program processes and components the TC had 
introduced to help retain females in treatment. Specific program components 
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introduced by the TC to support female clients include that female clients were 
always offered the choice of a female counsellor, and that there was an emphasis on 
individual counselling rather than confrontational mixed-gender group therapy typical 
of many TC’s. Women were also housed in separate living quarters with strict rules 
about access to those quarters, and the agency provided gender-specific therapy 
groups, parenting education, and access to specialist gender-specific services in the 
community. These women-sensitive treatment components in residential services 
have been previously reported as contributing to retention of females, and some of 
these findings are summarised by Greenfield et al. (2007). These program factors may 
have contributed towards female retention rates in this sample comparable with the 
male clients; however other factors possibly influencing female retention will be 
examined next.  
 
Gender and Anxiety, Depression & Self-Esteem Scores at Treatment Entry 
Previous research has indicated that females were more likely to enter 
substance abuse treatment with higher levels of depression and lower levels of self-
esteem, and that these women were more likely to drop out of substance abuse 
treatment prematurely (Haller, Miles, & Dawson, 2002; Wilke, 2004).   
Consistent with previous findings many of the females entering the TC 
reported high rates of depression with 57 of the 84 females (68%) reporting clinical 
levels of depression (27-60 range) as measured at entry by the CES-D. In comparison, 
only 73 of the 150 males (49%) measured in this range at treatment entry. A higher 
percentage (50%) of females (82) remained in this higher level of depression scores at 
2 weeks after entry, compared to 47 of the 143 males (33%). By 8 weeks however, 
gender differences had mostly disappeared with only 9 of 59 females (15%) 
remaining in the high depression level, compared to 14 of the remaining 104 males 
(13%). There was a steady drop in mean depression levels for both males and females 
after treatment entry. 
The finding of high depression level scores for both males and females 
entering the TC replicates previous findings that it is common for clients to enter 
residential treatment with relatively elevated scores of psychopathology, especially 
depression. The fact that depression scores decreased quickly for many clients, 
reinforces previous findings of many researchers who note that staff should be 
cautious of making mental health diagnoses at treatment entry. The findings of this 
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study replicate previous findings noting there is a decrease in depression scores for 
many clients during the initial weeks following residential treatment entry and 
initiating abstinence from substance use (Gossop, Marsden & Stewart, 2006). 
Females in the sample did not report consistently lower levels of self-esteem 
compared to males, and no females scored in the lowest self-esteem range at treatment 
entry. When comparing the other self-esteem ranges, 94 of 150 males (63%) scored in 
the medium self-esteem range at treatment entry, compared with 59 of 84 females 
(70%) scoring in that range. 54 males (36%) scored in the highest level of self-esteem 
at treatment entry, compared to 25 females (30%) scoring in the highest range.  
By 2 weeks after treatment entry, no male clients scored in the lowest level of 
self-esteem. By 8 weeks, 20 of 104 males (19%) reported medium levels of self-
esteem, compared to 18 of 41 females (44%). 84 of 104 males (81%) scored in the 
highest range of self-esteem, and 41 of 59 females (69%) also scored in this range.  
After 14 weeks following treatment entry, only 6 males (9%) of the remaining 67 
males, and 6 females (18%) of the remaining 33 females, were in the medium range 
of self-esteem scores.  The large majority of clients, 61 (91%) of the remaining 67 
males were in the high range of self-esteem, and 27 (82%) of the remaining 33 
females were also scoring in the high range of self-esteem. 
The general increase in client self-esteem following residential treatment entry 
reflects previous findings that self-esteem increases over treatment time for women 
(Wilke 2004). However not all studies have reported a mean increase in self-esteem 
scores during residential substance abuse treatment. Malcolm (2004) reports a study 
of 305 homeless male substance abusers residing in a residential treatment facility 
who were compared to a control sample receiving community-based treatment. Self-
esteem scores did not show a major change over time for either group, and the mean 
self-esteem score for both groups was slightly lower at immediate post-treatment (3 
months), and at other time intervals following, than mean self-esteem scores at the 
initiation of treatment. The author notes that for their sample of homeless males, self-
esteem scores do not necessarily increase following decreased substance use.  
There was no consistent major gender difference in self-esteem scores at 
treatment entry for the sample, and this contradicts the findings of many other reports 
stating that women are more likely to enter treatment with lower self-esteem. 
Women’s self-esteem scores in this sample also increased over time similar to 
increases in the men’s self-esteem scores.  
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It is possible that the analysis and tools used to measure psychopathology in 
this sample were insufficient to capture important patterns of psychiatric problems 
and score change over time. It is therefore possible those women entering treatment 
with greater depression scores also reported lower self-esteem scores than males 
entering treatment with similar depression scores, and those women were less likely 
to improve in depression and self-esteem over time. Edokpolo, James, Kearns, 
Campbell, and Smyth (2010) report the results of a relatively small sample of 
adolescents (65 males and 23 females) seeking substance abuse treatment. They note 
that although the sample was small, the females reported much higher internalising 
and externalising psychiatric scores than the males, and that the female comorbidity 
patterns were often more complex than for the males in the sample. The authors note 
that distinct comorbidity patterns within clients may account for different etiological 
roles in the development of substance abuse problems, and consequently have 
different treatment requirements and outcomes. The authors suggest that increasing 
self-esteem may be more important for female clients than male clients during 
substance abuse treatment. 
 
Retention and Depression, Anxiety & Self-Esteem Scores 
 The first set of analyses utilising all independent variables (Analyses 18-22), 
indicated that clients with medium and high levels of anxiety at treatment entry were 
significantly more likely to be retained at 8 weeks. Clients with high levels of 
depression at treatment entry were significantly more likely retained at 8 weeks in 
both sets of analyses. Clients with high levels of self-esteem at treatment entry were 
significantly more likely to be retained at 14 weeks in both sets of analyses (18-27). 
The finding that clients entering the program with high levels of depression and 
anxiety were more likely retained at 8 weeks was not expected. As previously 
described, the majority of previous retention research findings have reported that 
client mental health problems are more likely to predict treatment attrition. 
It is possible that specific program factors may account for the finding that 
clients with high levels of anxiety and depression were more likely to remain in the 
program. Two specific program factors that have been previously noted as important 
in affecting client retention is the relative number of allocated clients per counsellor 
(Hser, Joshi, Maglione, Chou, & Anglin, 2001), and the level of counsellor 
qualifications (Simpson, Joe, Rowan-Szal, & Greener, 1997).  
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Although weekly client counselling forms a major part of most residential 
treatment programs, Simpson et al. (1997) report that the effectiveness of counselling 
on retaining substance abusing clients in treatment has primarily been demonstrated 
only for qualified and experienced counsellors. Hser et al., (2001) undertook an 
extensive analysis of retention involving 26,047 clients in 87 Los Angeles County 
substance treatment programs, and noted that staff qualifications was an important 
program factor helping predict retention in most programs. Despite these findings of 
the importance of counsellor qualifications influencing client retention in substance 
abuse treatment services, Meier, Donmall & Heller (2004) report a survey of 326 
English and Welsh specialist drug treatment services, and report that only 17% of 
these services provided counselling by accredited counsellors. The survey collected 
responses from 58 services who were identified as residential treatment services, and 
51 (88%) of these services provided individual counselling to clients, but few of the 
counselling staff had any formal counselling qualifications.  
This author is not aware of  Australian statistics regarding the percentage of 
residential treatment staff having formal counselling qualifications, but during the 
time of data collection it was not required that residential substance abuse treatment 
programs employ accredited counselling staff. Despite the lack of state requirements, 
the majority of the Palmerston Farm counselling staff were graduate trained, and the 
program employed at least one post-graduate clinical psychologist in a senior clinical 
role throughout most of the data collection period. Employing senior clinical staff 
with counsellor supervisory responsibilities also enabled the training of clinical 
psychology trainees in the clinical program during those years. The counsellor:client 
ratio during this period was approximately 4 to 5 clients per counsellor, reflecting a 
low counsellor client load when compared to most U.S.A. and U.K. residential 
treatment programs. Hser et al. (2001) note that a low number of clients per 
counsellor can help prevent counsellor burn out, and predicts improved client 
retention rates. 
The post-graduate clinicians in the TC program were usually allocated to 
clients of the same gender who had been identified at treatment entry with elevated 
anxiety and depression scores. The interventions with the higher risk clients were 
primarily cognitive behavioural therapy (CBT) in orientation, and tailored to suit 
individual client needs. The relatively low caseloads of the counselling staff, 
mandatory weekly supervision of counsellors by senior experienced clinicians, and 
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the use of post-graduate trained clinical staff in residential substance abuse treatment 
programs for client counselling is uncommon in residential substance abuse treatment 
settings. These specific program factors may have influenced the findings, and may 
therefore also restrict generalisation of the findings. 
Another specific program factor that may have influenced the retention finding 
of this study was the program began allowing client use of prescribed psychoactive 
medications for various mental health disorders from 1999, and during the following 
6 year period of data collection. The effectiveness of psychoactive medication use in 
improving client substance abuse treatment retention in Australian TC or other 
residential substance abuse programs has not been widely reported or researched.  
Other specific program factors that may have influenced reported retention 
findings in this study include that the program reduced the availability of packaged 
food, drinks with high sugar content, tobacco, and music and television use. A strong 
emphasis was also placed on the importance of utilising appropriate social support 
within the community, healthy nutrition, exercise, recreation, appropriate sleep 
patterns, and engagement in meaningful work activities. The work activities involved 
training in various tool uses (e.g. welding, fabrication and construction), tractor and 
other machinery use, property maintenance, and the commercial production of 
accredited organic fruit and vegetables. Various work activities involving both staff 
and clients were scheduled on most week-day mornings from 7am-11 am. 
Although there is no research indicating the effectiveness of work-related 
program structure factors contributing to client retention, experienced senior program 
staff believed meaningful work activities and the mandatory introduction of healthier 
lifestyle factors helped reduce client anxiety and mood symptoms, and thereby 
encouraged program retention. These regular activities could be described as a form 
of “behavioural activation” (Martell, Dimidjian & Herman-Dunn, 2010), which has 
been shown to be an effective intervention for depression. The engagement of client 
interest in improving various aspects of their lifestyle may have also had beneficial 
effects in engaging client trust. Improved trust and therapeutic alliance between staff 
and clients has been shown by several studies (Corrigan & Bogner, 2007; Curran et 
al., 2009) to positively affect treatment retention rates.  
 
 
 
86 
 
Therapeutic Community Retention 
 
Age and Treatment Retention 
 The older group of clients (30-50 year olds) were more likely to leave 
treatment before 14 weeks when including the depression, anxiety and self-esteem test 
scores at 8 weeks in the first set of analyses. The second set of analyses indicated that 
the 24-29 year old group were more likely to leave before 14 weeks compared to the 
younger group of 17-24 year olds when including the 2-week depression, anxiety and 
self-esteem test scores. The 30-50 year old group were more likely to leave treatment 
before 14 weeks compared to the younger group of 17-24 year old group when 
including the 8-week test scores. 
The finding that the youngest group of clients were less likely to drop out of 
treatment is not supported by the majority of research findings regarding residential 
treatment retention. Most previous retention studies have reported that older clients 
are better retained in substance abuse treatment (Joe, Simpson & Broome, 1998), and 
state that this is a reflection of older persons usually having greater motivation to 
change their substance use patterns. Brecht, Greenwell, and Anglin (2005) analysed 
10 years of data for methamphetamine treatment admissions to Californian services, 
and reported that clients with limited education, more severe drug use, injecting drug 
use patterns, and being younger were more likely to drop out of treatment.  
One possible reason why the younger client group was better retained in this 
treatment sample is that their drug use history was generally shorter and less severe 
than older clients. Numerous studies report that clients with a longer and more severe 
substance use history usually have a history of relapsing and treatment failure, 
(Williams & Chang, 2000).This current study was unable to include these factors in 
the analyses as drug use severity and drug-using history were not recorded in the 
programme’s archived data set. 
It also remains possible that specific program factors relating to the TC may 
account for the finding that the younger clients were more likely retained in treatment. 
One distinct part of the Palmerston Farm TC was the incorporation of a variety of 
work activities within the therapeutic program. These mandatory work activities 
included community meal preparation, general property maintenance, automated 
irrigation maintenance, a tree and plant nursery, care of a range of animals, and the 
commercial production of a wide range of certified bio-organic foods. Many of the 
younger clients in the program reported little past engagement in paid employment 
work, and consequently possessed limited employment work skills. Most clients were 
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generally keen to engage in the program’s work-related activities; however it is 
possible that older clients with more experience in the paid work force were more 
reluctant to engage in unpaid work for relatively long periods within the program.  
During the latter part of this data collection period, the program had initiated 
the accreditation process of having various work skill acquisition components of the 
program formally recognised. This initiative was especially welcomed by the younger 
clients who often reported having no formal training or work qualifications. The 
program also trained interested residents in bulk food purchasing, meal planning, food 
preparation, kitchen and personal hygiene, food storage, cooking and related kitchen 
responsibilities, and accreditation for these skills was also being sought.   
Although differences in client work engagement attitudes were not measured, 
it is possible that greater work engagement positively affected client mood, anxiety 
and self-esteem levels, such that work was indirectly influencing the retention of 
younger clients. The influence of therapeutic involvement in residential programs 
positively affecting retention of young adolescent clients has been previously reported 
by Hawke, Hennen, and Gallione (2005). The authors note that therapeutic 
involvement facilitates the recovery process and also manifests as improved trust and 
positive rapport with program staff.  
 
Primary Drug and Retention 
There was no significant finding for primary drug of abuse although clients 
who had indicated opiates as their primary drug of abuse were more likely to leave 
treatment prior to 8 weeks. This finding was unexpected as previous research had 
indicated greater difficulty for programs retaining methamphetamine-abusing clients, 
rather than clients who had nominated other substances as their primary drug of use 
(Maglione, Chao & Anglin, 2000). Considerable research has been published 
regarding the complexities of treatment for methamphetamine users in the last decade. 
This includes research findings indicating that methamphetamine use often results in 
extended withdrawal periods, and is associated with a range of mental health 
problems affecting treatment retention (Dyer & Cruikshank, 2005; and Glasner-
Edwards, Mooney, Marinelli-Casey, Hillhouse, Ang, & Rawson, 2008). Other studies 
have failed to find a significant effect for methamphetamine influencing substance 
abuse retention (Hammerbacher & Lyvers, 2006), or post-treatment 1 year treatment 
outcomes, (Luchansky, Krupski, & Stark, 2007).  
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Table 3 indicates that only 25.8% of the opiate–abusing clients in this sample 
were in the youngest age group (17-23 years), compared to 38.6% of 
methamphetamine users being in that age group. The mean age of the opiate group 
(28 years) was older than the mean age of the methamphetamine-using group (25 
years). As previously noted older clients were more likely to leave treatment before 
14 weeks. Another possible reason that young methamphetamine clients were retained 
in treatment is that the program allowed continued client use of prescribed 
psychoactive medications. Many of the methamphetamine using clients entered the 
treatment program with high levels of anxiety and depression scores, and although 
these measures tended to quickly decrease in the large majority of clients, senior 
clinical staff believed that prescribed medications appeared to support some clients 
through the initial stages of the treatment program.  
 
Psychoactive Medication Use and Retention 
Both sets of analyses indicated that the clients who had been prescribed 
psychoactive medications were significantly more likely retained in treatment at 14 
weeks when analysed with 8 week depression, anxiety and self-esteem scores. High 
self-esteem and medication use were the only significant predictors of 14 week 
retention. The finding that the client group taking psychoactive medication were more 
likely retained at 14 weeks appears to validate the decision by this agency to change 
its existing policies in 1999, and begin accepting clients to their residential service 
who had been prescribed various psychoactive medications.  
This author is not aware of previous published research regarding prescribed 
psychoactive medication use affecting substance use residential treatment retention. 
The fact that pharmacotherapy may help improve the retention of clients has been 
noted however, and in particular Haller and Miles (2004) note that many women who 
enter residential treatment with high levels of psychopathology may be helped to 
remain by the availability of prescribed psychoactive medications. This author is not 
aware of information indicating the frequency of prescribed medication use in 
Australian residential substance abuse treatment centres. Knudsen, Ducharme, and 
Roman (2007) report the results of a large survey of medication use in 403 privately 
funded and 363 publically-funded treatment services in the USA. They note that less 
than half of these services (49.3%) allow the use of SSRI medication, and only 21.2% 
allowed Naltrexone use. They report a tendency for 12-step based programs to not 
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allow medication use, and for medication use to be adopted by those services with 
detoxification facilities, access to physicians, and who employ a high proportion of 
Master’s-level counselling staff.   
From early 1999, the Palmerston Farm TC began accepting clients prescribed 
various psychoactive medications. The rapid increase in the availability of 
methamphetamines in Western Australia (W.A.) from the late 1990’s appeared to 
coincide with a large increase in young persons applying for entry to the service who 
had been diagnosed with various mental health problems including psychoses. The 
influx of large numbers of young clients with methamphetamine-abuse problems 
having concurrent mental health difficulties and prescribed psychoactive medications, 
resulted in a significant increase of tension within the existing clinical team. The 
majority of the program’s counselling staff had no experience with 
methamphetamine-using clients, and believed the TC should not admit clients 
prescribed psychoactive medications. Program management persevered with the 
policies allowing medicating clients, and consistent with findings reported by 
Knudsen et al. (2007), were able to support existing clinical staff by increasing the 
number of clinical psychologists on the team, and forging closer ties with the local 
public mental health services. Within two years of changing client medication policies 
and increasing the number of post-graduate trained clinical staff, the average length of 
client stay in the TC more than doubled to 100+ days, and remained above 100 days 
for the following years of data collection. This significant increase in the client 
average length of stay occurred despite the increased complexity of client 
presentations. 
The finding in this study that clients prescribed psychoactive medications were 
significantly more likely to be retained in the program at 14 weeks, suggests client use 
of prescribed psychoactive medications may be helpful in achieving improved client 
retention rates in AOD residential treatment services. Few treatment retention studies 
have reported if clients are prescribed medications, and counselling qualifications and 
other program factors may be confounding factors in this study, so the usefulness of 
client medication usefulness requires further investigation from other client retention 
studies where possible effects of this variable on retention have been analysed.  
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Stage 2 
 
The second stage of this study involved qualitative analysis of focus group findings 
where the primary quantitative findings from stage one of this study were presented to 
Chief Executive Officers, Program Managers and senior clinicians from major 
Australian and New Zealand therapeutic communities for feedback and general 
discussion.  
  
Stage 2 Aims 
The primary aim of the stage 2 focus group was to explore the implementation value 
of the Stage one findings. The focus group presented the Stage one findings to the 
focus group participants who were all well experienced with TCs. Feedback about the 
stage one findings was sought, followed by an exploration of barriers and possible 
solutions to implementing knowledge of identified stage one variables influencing 
treatment retention and attrition in therapeutic community treatment programs.  The 
aims of the second stage were framed as the following three questions to participants: 
 
What are the participant’s thoughts or reactions to the Stage 1 findings? 
Can participants identify any barriers and possible solutions to including knowledge 
of the identified Stage 1 client factors in this study that predict attrition in TCs?  
What other factors may be likely influencing client attrition and retention within TCs?  
 
Stage 2 Method 
The second research stage was qualitative research involving a single focus group 
with senior representatives of leading Australian and New Zealand TCs. The analysis 
was undertaken using a thematic analysis method whereby major themes were 
identified from analysis of the focus group transcript. Sub-themes of the major themes 
were identified and explored with reference to the relevant published literature.  
 
Participants  
The Program Managers and senior clinicians of various non-government 
agencies providing AOD therapeutic community (TC) services within Australia and 
New Zealand were invited to participate in a focus group session lasting 
approximately one hour (Appendix A).The nominated participants were attending the 
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2011 Australasian Therapeutic Communities National Conference held in Fremantle, 
Western Australia and were invited to participate in the focus group by this author. 
There were five male participants and four female participants representing 
therapeutic community services based in urban Australian cities, a New Zealand city, 
and one remote Australian community.  
 
Stage 2 Procedure 
Once participants had agreed to take part in the focus group, they were 
provided with an information letter (Appendix B) outlining the nature of the study.  
All participants were required to sign a consent form prior to participating in the focus 
group, and were provided with the opportunity to clarify any issues regarding the 
nature of the research. They were informed of their right to withdraw from the 
research at any stage without any adverse consequences. Focus group attendees were 
advised that the discussion was recorded by audio recording, and were assured that all 
comments remained confidential and non-identifiable, and that only the primary 
researcher would transcribe the taped session. 
Initially the researcher described the proposed primary research goal of 
exploring hypothesised relationships between factors believed to contribute to 
residential treatment retention and attrition. The focus group sought to elicit 
participant responses to the stage one research findings, explore barriers and solutions 
to incorporating knowledge of the identified variables affecting client attrition and 
retention, and discuss alternate methods of retaining clients at higher risk of attrition. 
Each dependent variable from the initial stage of the study was discussed with the 
participants who provided feedback about their perception of the relevance of those 
variables in affecting TC treatment retention and attrition. The majority of participants 
generally agreed with the findings presented, and these responses were further 
explored for possible reasons why some of these findings differed from previously 
reported findings in the literature. Participants described what they believed were 
other important factors affecting client treatment attrition and retention in their 
respective therapeutic communities. Various solutions and barriers to client retention 
problems were also explored.  
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Stage 2 Analysis 
The audio recording was transcribed verbatim and analysed using thematic analysis 
(Braun & Clarke, 2006) to determine themes relevant to participant perceptions and 
comments regarding the research findings. The thematic analysis procedure involved 
careful multiple readings of the transcription, before identification and grouping of 
participant comments into major identified themes, and sub-sets of the major themes.  
 
Identified Themes and Sub-Themes 
After thorough analyses of the data set a decision was made to code the data collected 
from the focus group into two broad themes, named “client factors” and “program 
factors’. These two themes were constructed to further sort the data-set statements 
regarding the various variables hypothesised to influence client retention and attrition. 
The two major themes included all variables that were the focus of the first stage of 
the study, but also included other factors believed by many of the participants to be at 
least equally important for improving or at least influencing client retention. 
 
The various variables from Stage 1 that were presented to the group for discussion 
have been listed as sub-themes of a broad theme labelled “client factors”. The sub-
theme of client motivation in this group was not included in the initial stage of the 
study, but recognised by all participants as a major dynamic client factor influencing 
treatment retention, and has been included under the primary theme of client factors. 
All participants noted that various non-client factors were very important influences 
on client retention and attrition. These factors have been collected under the broad 
theme called “program factors”. The two major themes identified of “client factors” 
and “program factors”, and the respective sub-themes of each are listed in Table 14. 
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Stage 2 Results  
Table 38 
Major Themes of Client & Program Factors, and Sub-Themes 
Client Factors Program Factors 
Age TC Model Practices 
Gender TC Medication Policy 
Primary Drug TC Client Dynamics 
Mental Health  TC Staff 
Motivation  
 
 
 
 
The themes identified by the thematic analysis were reduced to two major themes of 
client factors and program factors. The previous stage 1 independent variables were 
identified as sub-themes of the client factors; and the sub-themes of the program 
factors were identified by the focus group participants as factors they believed were 
also relevant to client retention and attrition. These sub-themes of both the major 
themes of client and program factors will be discussed in turn with reference to the 
relevant research literature. 
 
 
Stage 2 Discussion 
Major Theme - Client Factors 
Client Age 
The finding that older clients were more likely to leave treatment early compared to 
younger clients received minimal feedback from the group. One service manager 
mentioned that most of their clients would fit into the young age category (18-24 
years) described by the current study. Several managers stated that their service did 
not experience problems retaining young clients because they adapted their TC 
program years ago to better retain the younger clients coming to their service.  
 
94 
 
Therapeutic Community Retention 
 
Most participants agreed with a statement by one manager that services can retain 
younger persons in the TC, however they noted that younger clients are more prone to 
boredom and it was necessary to maintain a well-structured program for them. 
 
“You can retain them in the TC, so long as you keep them busy”.  
 
The manager of the agency servicing remote aboriginal communities noted that they 
mostly have older clients (50+) in their service, and that although younger clients may 
enter the service, their retention is dependent on there being others of a similar age.  
 
”Our age group is all the older age group (50+). But we do get younger ones 
in, however we find that those younger ones… that if there is not already an 
age group around their age group, then that young person will not stay.” 
 
Possible client attrition due to a population comprised of significantly different age 
groups within a particular substance abuse program has not been a focus noted in the 
treatment retention research literature. It is possible this is because there has been a 
tendency in the last two decades in particular for the establishment of adolescent-
specific and alcohol-specific services. Despite the possibility of retention problems 
due to client age differences, the majority of participants agreed that some positive 
outcomes are gained by mixing clients of different ages within a treatment service. 
 
“We have got four houses on our campus, and originally our place was 
organised where you started at House # 1, then went to # 2, then # 3, and 
House # 4 was the women’s house. So one of the things we did was actually 
mix the houses, so it’s not rocket science, so you have older people looking 
after the younger people, and that has made a significant difference to our 
(client) retention”. 
 
This importance of older and more senior clients helping younger clients orientate to 
the rules and processes within the TC so the younger clients are more likely to remain 
in treatment was described by a New Zealand program manager who stated: 
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“If you don’t have older people there, you are kind of expecting the people to 
lick it off the grass or something, to kind of get the understanding of what is 
going on.” 
 
“And they wonder why it is so unhealthy, and why it isn’t working” (Stated in 
context of without there being any older residents around to instruct newer 
and younger residents). 
 
 The exchange below was between two group participants discussing the use of older 
residents to visit an off-site pre-admission house to help orientate prospective TC 
residents: 
 
“In our pre-admission house we take some of the older residents to stay the 
night.” 
“That’s a good idea.” 
“It’s also good for the older residents too.” 
 
In describing the components of a generic TC program De Leon (2000) states in 
reference to the importance of residents helping each other : “All members of the 
community are expected to be role models – roommates; older and younger residents; 
junior, senior, and directional staff. TCs require these multiple role models to 
maintain the integrity of the community and assure the spread of social learning 
effects” (De Leon, 2000; p. 383). This statement reflects participants’ belief that client 
retention is likely to improve when there is mixing of different aged clients within a 
spirit of mutual help fostered by clients and staff in the TC. 
 
Following the discussion of client age effects on treatment retention, the next 
hypothesised retention variable that was discussed was client gender differences.  
 
Client Gender 
The finding of no significant gender differences in treatment retention was 
accepted and agreed by the majority of participants. Most participants agreed that 
women are a minority in most of their TC services, and that they often arrive with 
more severe mental health issues. Several participants mentioned that they had 
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introduced specific program factors into the services in recent decades to better retain 
and support women. These factors included separate rooms and houses, gender-
specific group work, and same-sex counsellors where possible.  
 
“Women come into treatment a lot more damaged than men. It’s easier for 
men to get into treatment. By the time a woman gets there, they are a lot more 
damaged. Learning how to work with that, and in a way with those separate 
rooms and different places.” 
 
An important issue that emerged during the discussion was the provision of 
gender-specific housing. One manager of an Australian residential agency servicing 
rural and remote aboriginal communities mentioned that it was almost impossible to 
be referred or to retain aboriginal women in that service until they could offer women-
only accommodation.  For example: 
 
“We actually had to set up a specific women’s house because of the cultural 
factors around that. We found that if we have more than one or two women in 
(the service), that they will always stay, and they will stay the full term; but if 
we have less women in, the less they will stay around.”  
  
A large review of published literature from 1975 to 2005 of substance abuse treatment 
entry, retention and outcomes for women by Greenfield, Brooks, Gordon, Green, 
Kropp, McHugh, Lincoln, Hien, and Miele (2007) noted that women were generally 
less likely than men to engage with any specific substance abuse treatment service, 
especially residential services. The authors note that women were more likely than 
men to engage with mental health services for their substance abuse problems. They 
also note that women with trauma histories, including sexual and physical assault and 
abuse may be less attracted to mixed-gender treatment services.  
 
“We found we had to keep space for women, not to fill the house with men. We 
had to keep so many beds, and make a woman friendly area.”  
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The importance of gender specific areas and housing seems to be even more critical in 
the rural and remote TC programs servicing Aboriginal populations as captured by the 
following statement of a service manager: 
 
“People in the community won’t refer to us until they spoke to me about 
identifying a specific house for women. And we did that and we assured them 
there would never be a male within that environment. Once we guaranteed 
that, our numbers went up by 700% within the first six months.”  
 
Baird (2008) examined the literature regarding various barriers for women entering 
substance abuse treatment and noted there was considerable evidence that many 
women do not enter residential treatment in particular because women are generally 
the primary childcare providers. The Greenfield at al., (2007) review also noted that 
there were more barriers for women than men to initially enter substance abuse 
treatment, however once they had entered treatment their retention and outcomes were 
often reported as better than the males. Another important point raised in the 
discussion was the comment that many women may leave treatment early because of 
family and other responsibilities.  
 
“Yes females accessing that service and again, that ideal of women 
completing the program, there are many variables around that you have to 
take into account. But they were more stable in the long-term, and accessed 
the transitional after care program with the one-on-one program in the home 
environment, and stuff like that. They accessed that more than the men did, 
and used that support system well.” 
 
“…because a lot of women chose not to complete 6 months because they were 
going back to families. It didn’t necessarily mean that treatment was a failure; 
it meant that there were personal and other responsibilities. What we found in 
the same research was that whilst we got fewer women through to completion, 
the women in the longitudinal studies did better”. 
 
This statement supports previous findings regarding the difficulty of retaining 
some female clients in residential treatment. The Greenfield, et al., (2007) review 
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noted that several previous studies reported that treatment retention was influenced by 
the number of children the female client had (the more children, the less likely to be 
retained), and whether the female client received sufficient support from their spouse 
or family influenced their retention in treatment. The next hypothesised treatment 
retention variable that was discussed was the clients reported primary drug of abuse. 
 
Client Primary Drug 
The majority of participants answered “No” to the question of whether they 
believed that the primary drug of abuse helped predict client attrition. Upon further 
exploration of this response it became apparent that most of the TCs had adapted their 
treatment programs during the last decade to better retain the younger clients coming 
to their treatment services with amphetamine/methamphetamine problems. This 
indicates that retaining the particular client group of methamphetamine users had 
previously been more difficult, and this was captured by the following statement by 
one of the New Zealand program managers:  
 
“What (X) was saying before, about 12 years ago when methamphetamine 
first came to New Zealand we had to learn how to work differently. Right so 
that was keeping it really busy for the younger ones. That was a really 
important part, so we did change, and that has helped retain them… how we 
learned to work with methamphetamines.” 
 
The key point noted by this manager was their service was able to improve retention 
of young methamphetamine clients in their TC by changing their program to keep the 
younger clients sufficiently engaged and occupied. This is an important point because 
it indicates that programs and treatment staff are able to positively and successfully 
respond to particular demands and needs to improve the retention of young persons.  
 
“We struggle the most with their retention...opiates.” 
 
“I think that’s true of Opioid users who tend to leave our service program 
earlier, and are less disaffected by mental health issues including anxiety and 
depression, and they have been well serviced over a period of time.”  
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Several participants noted that they now struggle to retain opiate users in TC 
treatment, and one manager of a service that accepted clients prescribed Methadone (a 
synthetic opiate), noted that they tended to lose many younger male clients 
prematurely from their program because they wanted to return to using illicit opiates 
in the community: 
 
“What we kind of concluded, and remember that Methadone might be part of 
it, was that this group of men who were the youngest kids, were keen to get off 
(Methadone), and “get on” (start using opiates again). This was a group of 
men who were starting to get quite entrenched and possibly hadn’t finished 
(using). Do you know what I mean?” 
 
There was general agreement with the first stage finding of this study that 
retaining opiate users in treatment was now more difficult than retaining 
methamphetamine users; however no reasons were offered to explain this change. It 
was apparent that some TCs had successfully responded to the growth of a generally 
younger population of methamphetamine users in their services by introducing 
program adaptations designed to improve retention of this group by keeping these 
clients occupied, motivated, optimistic, and better engaged with staff and more senior 
residents. It is not possible from the analyses undertaken here however to determine if 
these various program adaptations to better hold methamphetamine users in treatment, 
have inadvertently influenced the attrition rates of clients with opiate use problems.  
 
Client Mental Health 
The finding that clients reporting high levels of depression and anxiety at 
admission were more likely to be retained at 8 weeks was accepted by the majority of 
participants who agreed that these clients are not more likely to leave treatment 
prematurely now. Several managers commented that many of the clients entering 
treatment with elevated mood and anxiety scores are more likely to remain in 
treatment than clients without these mental health problems. Two managers noted: 
 
“We found that the clients that reported the highest psychological distress at 
admission appeared to be the people that stayed longer, and they were also 
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the people that tended to engage themselves in as many of the services, both 
medically and externally that our program had to offer.” 
 
“I know the more disaffected they are by mental health, and drugs and 
alcohol, the longer they stay here, that’s true.” 
 
One manager noted that retention of clients with mental health problems was 
influenced by the perception of other clients, and therefore the presence of others with 
mental health problems makes it easier for those persons to remain in TC treatment. 
 
“I can see that when we have a community when there’s a higher level of 
dysfunction, dysfunctional people are more likely to stay” 
 
The large analysis of 58 published studies examining the effects of mental health 
problems and substance abuse treatment retention and attrition undertaken by Meier 
and Barrowclough (2009) noted that elevated depression scores did not consistently 
predict retention or attrition. The authors note that several studies reported that more 
severe depression predicted retention, whereas mild depression did not. They also 
note that two studies suggested an interaction between service modality and retention, 
in that depressed clients were more likely to remain in residential treatment 
programmes, but not necessarily more likely to remain in outpatient or methadone 
programmes. 
This finding that the more severely depressed clients are likely to remain in 
residential treatment is consistent with the report of the service manager quoted above 
who suggests the more depressed clients may be more likely to remain in treatment to 
better access medical and other services offered by the agency. Another TC manager 
noted that their service provided a range of mental health medical services that they 
believe better enabled their service to hold on to clients with a variety of serious 
mental health issues: 
 
“So we have had psychiatrists for about 20 years, and a GP on site, and a 
nurse for the last 20 odd years (a mental health nurse). So they are tested at 
the beginning and medicated if they need to be, and that is continuous, so the 
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high end users do tend to stay, and those people do include poly-substance, 
including methamphetamines, and they are young as you said.” 
 
This statement reflects the suggestion by Knudsen, Ducharme, and Roman (2007) that 
services that implement evidence-based policies allowing client use of prescribed 
psychoactive medications with the support of supplementary psychiatric and mental 
health services may be better able to service and retain client groups with complex 
mental health and substance abuse (comorbid) problems. 
 
This pro-medication use statement by this program manager did arouse 
substantial reactions from two others managers who disagreed with providing clients 
with psychoactive medications to better support clients with mental health problems. 
The two managers stated that they did not allow client use of medications because 
they believed clients should be “drug free” to better enable appropriate assessment of 
their mental health. Both of these managers noted that their programs operated with a 
“drug-free” approach. Roman, Abraham, and Knudsen (2011) note that the use of 
medications in treatment services is still strongly opposed by many programs 
especially those services with a “12-step” and/or “drug free” approach. 
The primary issue conveyed in this discussion was that most services had 
adopted various measures in the last decade to better retain clients with mental health 
issues. Some services did this by providing relevant medical and social services, 
whereas other services sought alternative non-medication methods to support the 
retention of these clients. The issue of differing beliefs and policies about client use of 
medication is further discussed in the sub-theme discussion of medication use. The 
fact that some clients react negatively to remaining in a service with many persons 
having serious mental dysfunction was also mentioned during the discussion, as was 
the importance of client motivation for seeking and remaining in treatment.  
 
Client Motivation 
The majority of participants agreed with one manager’s statement that client 
motivation was the most important factor predicting client entry and retention in 
substance abuse treatment. It was agreed by all participants that a client’s motivation 
for treatment can be affected by many factors, and that motivation changes over time. 
Specific and common motivators mentioned by participants in regard to this included 
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the motivation not to lose a partner or children, the desire not to go to prison, the 
desire to find suitable work, to find stable accommodation, and the motivation to 
generally obtain a better quality of life.  
 
“Our only predictor (of client retention) is motivation. Reasons for coming to 
treatment. It’s the only one that we can establish.” 
Motivation for entering and remaining in substance abuse treatment has been 
the focus of much theory and research in recent decades. DeLeon, Melnick, and 
Kressel (1997) describe the critical role of client motivation to enter and engage with 
substance abuse treatment, and that treatment is believed to produce positive changes 
in the client leading to engagement, reinforcement and retention in treatment. 
Motivation was not included as one of the variables for study in the first stage of this 
study however, and hence discussion of this factor will be restricted. 
Residents enter substance abuse treatment with a range of internal and external 
motivational factors, and some motivations are believed to be more important than 
others in predicting treatment retention and outcomes. A recent paper by Klag, Creed, 
and O’Callaghan (2010) describing the role of various types of motivation in 350 
residents entering six Australian TCs is relevant to this point. The authors note the 
important role of non-autonomous motivation, or extrinsic motivation in clients 
seeking and entering substance abuse treatment. This type of motivation is described 
as regulated by the demands of others or external factors, and that people act in a 
certain way (e.g. enter treatment) to avoid negative consequences of continued 
substance abuse. Klag et al., (2010) note however that externally regulated behaviours 
are contingency-dependent, and show poor maintenance once the contingencies are 
withdrawn. One example of this in the substance abuse treatment field is some clients 
who enter treatment to avoid prison, and then return to substance abuse after the risk 
of imprisonment (or other external motivator) has passed.  
An earlier paper by Ryan, Plant, and O’Malley (1995) examining internal 
versus external motivation in clients seeking outpatient treatment for alcohol abuse, 
reported that clients high in internal and external motivation showed the best 
engagement and retention in treatment. Clients high in internalised motivation also 
showed good engagement and retention, whereas the clients low in internalised 
motivation showed poor engagement and retention irrespective of the level of external 
motivation. These results suggest that although residents enter treatment with a range 
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of internal and external motivations of varying intensity, it is important that the person 
engages with internal motivations for substance use cessation or improved control, 
during and following treatment to increase their chances of enduring positive 
outcomes.   
Some TC’s have trialled the use of specific interventions to either directly or 
indirectly enhance client motivation for the purpose of improving client TC retention. 
Soyez, De Leon, Broekhaert, and Rossel (2006) describe a trial undertaken in four 
Belgian TCs of a social network intervention for new clients. This intervention 
involved showing new clients and their family and friends, a video to orientate them 
to the TC, and an induction day with a following discussion with the TC staff. 
Compared to a control group of clients, the clients receiving the intervention were 
more likely to be retained in the TC and subsequent analysis revealed that the client’s 
perceived social support and motivation were significant factors enhancing retention.   
The manager of an agency servicing Aboriginal communities made a comment 
regarding remote Aboriginal client motivation to access and remain in substance 
abuse treatment. His comment reflects much of what has been stated in the research 
literature about the role of motivation of clients with substance abuse persons of all 
ages, genders, drug use patterns, mental health status, and from various cultures. 
 
“There’s always a crisis in their life. There’s always a crisis motivation for 
them coming into treatment at some point, whether it’s legal, whether it’s a 
family situation, whether it’s a personal one, and depending on that force of 
that motivation in their life at that moment, will dictate how long they will stay 
when they are completing it for us.” 
 
Client motivation will not only vary in motivation type and strength between 
individuals, but may vary between cultural groups, and change over time. This has 
important implications for TC clinical staff that need to understand and work with an 
individual’s motivation for entering and remaining in treatment.  
Despite cultural differences in client motivation for treatment and differences 
in program structure and characteristics within different cultures, there is evidence 
that very different substance abuse treatments are still effective. Moggi, Giovanoli, 
Strik, Moos, and Moos (2007) describe an analysis of the relationship between 
program characteristics, client substance use and psycho-social functioning at a one-
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year follow-up in a comparison of Swiss and U.S.A. residential treatment programs. 
The authors state that despite great differences in client characteristics, program 
content and intervention focus, similar outcomes were obtained at the one-year 
follow-up. The authors suggested that underlying processes of substance abuse 
treatment may enable the generalisation of treatment outcomes across cultures, but 
note that this was one small study that requiring further research. 
The underlying processes affecting the outcome of client substance abuse 
treatment such as client motivation are often referred to as “dynamic factors” 
influencing client treatment retention and attrition. These dynamic client factors have 
increasingly become recognised as significant factors predicting treatment attrition 
and retention, and have become a major focus of study.  
An analysis of factors associated with the retention of youth aged 13 – 19 
years in various New Zealand residential and outpatient substance abuse treatment 
programs undertaken by Schroder, Sellman, Frampton, and Deering (2009) reported 
that a range of dynamic client characteristics and program variables were more likely 
to predict treatment retention than fixed client characteristics such as gender, criminal 
history, mental health status and primary drug problem. The more important dynamic 
client factors found to be significant for treatment retention included having higher 
internal motivation, greater external pressure to engage in treatment, and expectation 
of positive treatment outcomes and general life outcomes. The study also noted two 
significant program characteristics predicted retention of youth, and these were 
involvement with set treatment goals, and positive relationships with staff.  
The importance of client motivation and positive client-staff engagement as 
predictors of retention rather than fixed client characteristic such as a client’s primary 
drug was mentioned during the discussion with the focus group participants. After the 
initial focus of discussion regarding the Stage 1 significant findings, the focus of the 
discussion shifted to participants discussing various “program factors” that they 
believed played an important role in determining client retention and attrition. The 
program factors identified by the participants are discussed in the following section. 
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Major Theme - Program Factors 
 
TC Model Practices 
Therapeutic communities (TCs) offer a specific form of residential substance 
abuse treatment with quite distinct program practices that has been described as 
“community as method” (De Leon, 2000, p.92.). Although these various practices 
may differ according to service philosophy, size and structure of the TC, and the 
particular population they are serving, many of the practices are common to most 
TCs. Some of these practices were noted by the focus group participants as important 
for engagement with new residents and thereby promoting their retention in treatment. 
All participants agreed with the usefulness of a “buddy system”, or similar 
process within TCs whereby new residents are helped by another resident to orientate 
to the community norms and expectations. This mentoring technique is very common 
in TCs and always involves the assigning of a more experienced resident to help 
support the new resident for the first few weeks after their entry to the community.  
 
 “A buddy system is very important.”  
  
“Yet those first few days and first couple of weeks, of actually getting people 
settled is more important than getting the medication stuff right I think.” 
 
The buddy system was a technique all participants acknowledged as important for 
helping to retain new residents because it facilitated their positive orientation to the 
community, the therapeutic program, and the many rules and community practices. 
Assigning a senior person as buddy or mentor who is more stabilised in treatment also 
lessens the likelihood of the new person gravitating to residents who may be 
ambivalent about treatment and therefore at an elevated risk of treatment attrition. The 
process of guiding and supporting a more vulnerable new resident commonly 
reinforces the older resident’s awareness of their own personal growth since being in 
the community. The TC model notes the importance of residents learning from all 
others in the community, especially those who have been there longer and progressed 
along their treatment path, and are therefore more senior within the typical 
hierarchical structure of residents within the TC community. Senior residents are 
required to accept a range of increasing responsibilities within the whole community, 
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especially the monitoring and supporting of more vulnerable new clients that occurs 
within the buddy system.  
There was agreement that the initial perceptions of a new resident entering the 
community are very important, and that attempts to make these initial perceptions  
positive is valuable in helping maintain their retention at this more vulnerable time. 
One method mentioned for helping new residents feel welcome when they enter the 
TC was having a welcoming ritual for them. One of the New Zealand TC services 
described their welcoming process. 
 
“It’s a cultural welcome where they actually have to come in and the whole 
community meets them, and they say who they are. It’s just a lovely welcome.” 
 
“I love the idea of having a welcoming committee. We looked at that and 
thought how we could improve it.” 
 
“We have started doing that, called a cultural welcome. So they use a 
‘palfrey’ when they come in. It’s very important.” 
 
“With singing, yes it’s traditional… Yes, it’s beautiful.” 
 
 Most TCs place importance on the person being welcomed to the community 
and helping them develop a sense of trust and belonging with program staff and other 
residents. De Leon (2000) describes the typical TC induction stage of treatment as 
lasting 30 days, and notes that clients are at highest risk of attrition during this stage. 
The TC buddy system and formal welcome are specific TC practices designed to help 
the new person orientate to the TC program’s requirements, rules and practices. These 
welcoming practices also play an important role in helping the new resident feel 
valued and supported when they are in a period when they are most vulnerable to 
treatment attrition.   
 
Medication Policy 
The provision of prescribed psychoactive medication to clients in TC 
treatment elicited some strong and opposing views that reflect broader divisions about 
this topic in substance abuse treatment centres of different modalities and treatment 
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philosophies in the USA, Australia and New Zealand. Interestingly, the finding from 
the first stage of this study that clients prescribed medications were more likely 
retained at 14 weeks was not challenged by any participant, and most participants 
acknowledged that medications can help support many people especially during the 
early stages of treatment.  
One issue raised by several participants regarding medication was whether 
persons prescribed psychoactive medication whilst they were still using alcohol and 
illicit substances, would have received an accurate diagnosis. A proponent of a “drug-
free” TC stated their position. 
 
“For some residents it can be more de-stabilising, because they are often 
prescribed their medication when they are still using, so they’re whole 
physiology is changing and a lot of residents who come through our 
rehabilitation were having had regular doctors that have been readjusting 
medication, or changing of medication, or in some cases there’s been over-
prescribing of medication. So in a sense it can almost work against some 
residents, because we first try and find someone on a stable basis for them to 
kind of work in the community, but we are also trying to find a stable basis of 
what is the medication they should be on, and what dose.” 
 
This perception above reflects the acknowledgement that it is very difficult for 
a mental health professional to discriminate symptoms of some mental illnesses from 
some symptoms of substance abuse. It is therefore common that clients who have 
been abusing substances and have been in contact with medical professionals prior to 
residential treatment entry will have been prescribed psychoactive medications for 
mental health symptoms that may be primarily substance-induced. An advantage of 
residential substance abuse treatment services is that staff can more reliably ensure 
that the client’s drug use has ceased. Because most mental health symptoms of 
substance abuse disappear or dissipate within the first few weeks of drug use 
cessation, more discriminate mental health diagnoses can therefore be assessed.  
Many TC and other residential substance abuse treatment services deny entry 
to clients currently prescribed psychoactive medications because these services don’t 
have medical or nursing staff that can monitor resident or dispense medications within 
their facilities (De Leon, 2000). Many substance abuse treatment services also do not 
108 
 
Therapeutic Community Retention 
 
have easy access to external mental health professionals or medical services 
experienced with undertaking mental health assessments of substance abusing clients.  
This lack of integration between mental health and substance abuse services 
remains problematic in many developed Western countries. Gil-Rivas & Grella 
(2005) report the results of a survey of administrators and staff in 10 mental health 
and 16 substance abuse programs in Los Angeles County in California, and note that 
there remains significant variation of integration between mental health and substance 
abuse services, and highly variable staff perceptions within both services of the levels 
of integration of these two types of services.   
The alternative viewpoint that there are advantages to client retention by 
allowing persons to enter residential treatment who have already been prescribed 
psychoactive medications, or who are prescribed medications soon after entry, was 
captured by the following participant’s comment: 
 
“That’s where I think sometimes it does help your cause, because one doesn’t 
know whether it is the anti-anxiety (medication?). Because coming off 
amphetamines they do suffer a lot of anxiety. There is a lot of symptoms here, 
depression and anxiety that comes with amphetamines specifically, so it’s 
really hard to know what’s going on, and retention is enhanced by giving them 
something that lowers that uptight and depressive feeling so they are less 
likely to leave”. 
 
The above statements express the situation of many residential substance 
abuse treatment services with respect to mental health assessment and comorbidity. 
The case argued by one of the participants above is that client psychoactive 
medication use can alleviate some common symptoms of substance use withdrawal, 
such as heightened levels of anxiety and depression. In support of this position of 
allowing medication, a large study of over 100 U.S.A. treatment services with war 
veteran client populations reported that inpatient programs with more medication use 
had lower attrition rates (Swindle, Phibbs, & Paradise, 1995).  
Many TCs have adapted their previous drug-free policies during the last 
decade by either allowing persons who have already been prescribed psychoactive 
medications to enter their treatment programs, or by having persons assessed and 
prescribed medications by trained mental health professionals within the service, or 
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having new clients with mental health problems screened and assessed by local 
medical practitioners or mental health professionals whom they regularly work with. 
 
“Well yes because we have an MOU with the mental health service, and we 
have a really tight relationship with them, and they talk about most things, so 
they kind of know who we are and that has built up over years and years. We 
have also got some staff co-located in the medical centre so they understand 
what we do, and we understand what they do, so we consult quite a bit.” 
 
However without close integration between the two services many 
community-based medical professionals are unfamiliar with discriminating mental 
health problems from substance-induced mental health symptoms, and symptom 
changes during the course of substance withdrawal. The following statements by 
several TC managers (mostly from services with drug-free policies), reflect this lack 
of service integration. The perception of many TC staff and managers is that many 
medical professionals inexperienced with working with TCs are over reliant on 
prescribing psychoactive medications for client’s transient mental health symptoms.  
 
“Every time you (we) get a new GP or you get a new Psychiatrist, you have to 
go through an education process.”  
  
“In many ways I feel empathy for the doctor, because trying to get a doctor 
not to use his prescription pad is like asking an addict not to use.” 
(Many laughs by TC managers who could relate to this common problem). 
 
“But that is the challenge that we are talking about though isn’t it? Educating 
what is different about someone being in a TC, to someone being held in the 
community. A doctor is totally responsible for that person (in the 
community).”   
 
Many modern TC’s have either employed their own mental health professional 
staff to counter this reliance on external professionals, or developed relationships with 
their local medical general practitioners and mental health professionals to allow 
improved exchange of information about mental health issues, substance abuse, and 
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the common course of client mental health symptoms following substance use 
cessation. These TC-medical relationships often take years to develop and changes in 
TC professional staff and/or local medical and mental health staff can quickly result 
in deterioration of the mutual understanding of each other’s professional work. 
Collaboration between mental health and substance abuse treatment services 
has often been problematic and divisive. A staff survey of Queensland mental health 
and substance abuse treatment services reported that insufficient collaboration 
between the services remained a major problem in dealing effectively with comorbid 
clients (Kavanagh, Greenaway, Jenner, Saunders, White, Sorban, & Hamilton, 2000). 
Although this survey of staff perceptions in mental health and substance abuse 
treatment services was undertaken over a decade previously, many of the reported 
problems of insufficient collaboration, mutual understanding and integration of these 
two services have continued in many developed countries (Gil-Rivas & Grella, 2005). 
One New Zealand TC service that did not allow psychoactive medication use 
by clients mentioned they alternatively used a pre-admission house to help people 
complete substance use withdrawal and better orientate to substance use cessation 
before entering the TC. They stated that this pre-admission service had significantly 
improved their residential retention rates by helping clients adapt to living without 
substance use prior to going into the residential service. They believed this orientation 
service helped persons cope with cessation of substance use and significantly 
decreased the need for continuing use of any prescribed psychoactive medications.  
 
TC Client Dynamics 
Several managers stated they believed that retention of clients with mental 
health problems especially was influenced by client dynamics with their TCs:  
 
“I can see that when we have a community where there’s a higher level of 
dysfunction, dysfunctional people are more likely to stay. Where there’s a 
community of a high level of dysfunction, if I’ve got some life skills I might 
only stay a few weeks and then get on with it. Whereas if there’s other people I 
can relate to in the community, whether they be from the same criminal 
background, or they seem to be of the same skill level as me, I’m more likely to 
stay on.”  
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 An important point noted by this manager is that there can be a large variation 
of client types in a TC at any particular time, and the “client mix” can effect attrition.  
The increasing recognition of client mental health comorbidity especially in recent 
decades led to the development of TCs that specialised in servicing that client group. 
These “modified TCs” were developed because it became apparent that some standard 
TC practices such as the more confrontational group work were unsuited for clients 
with major mental health difficulties (De Leon, 2000). Other modified TCs have also 
been developed to better retain clients by servicing distinct substance abusing 
population needs, including the needs of women, prison populations, adolescents, 
homeless men and women, HIV positive and AIDS clients, and methadone clients.  
These specialised or modified TCs are usually only available in areas situated nearby 
large urban populations where there is more likely to be sufficient demand for 
specialised residential treatment services.  
In smaller cities, and rural and remote areas, there is usually insufficient 
demand to justify funding specialised residential programs or TCs designed 
exclusively for particular substance abusing populations. In those cases, residential 
and TC staff must integrate more heterogeneous client populations and most treatment 
services rely on program rules, policies and support services to lessen the likelihood 
of negative client dynamics developing that may result in treatment attrition. Most of 
the residential substance abuse treatment services and TCs in Western Australia are 
non-specialised programs containing a wide variety of clients. 
Typical TC program policies designed to better retain heterogeneous client 
populations include specific group work for sub-populations within the TC, the use of 
the “buddy” system, and more considered allocation of counselling staff to meet the 
needs of particular clients. Other means of servicing specific client treatment needs 
within non-specialised services include the provision of supplementary services 
including mental health and medical services, child care, vocational training, activities 
to meet parole requirements, debt reduction services, gambling treatment, family 
therapy, relationship counselling and mediation, and post-treatment housing 
requirements. Despite the variety of specific services offered by these generic TCs 
and residential treatment programs, many clients nevertheless leave treatment early 
and this attrition is often attributed to dynamic factors within the client population.  
Common dynamic factors within TCs affecting client attrition are often 
triggered by clients breaching standard TC rules. These rules almost always include 
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client prohibitions of alcohol or other drug use, sexual relations between clients, 
interpersonal violence, vandalism, theft, and threats to clients and/or staff. Client 
dynamics within a TC quickly become negative when clients rule breaches are not 
quickly admitted or exposed. “Hidden” rule breaches commonly leads to a culture of 
secrecy, divisions within the client community, and commonly culminates in multiple 
client attrition. TC staff therefore emphasise the need for all clients to contribute to 
the “safety of the community” by early admission of rule breaches, and enforcement 
of the rules. This culture of openness and respect for rules is critical to the therapeutic 
health of the TC, but is usually a challenge to the norms and beliefs of clients from 
illicit drug-using cultures and/or prisons where keeping secrets, violence and use of 
threats is very common. 
New residents arriving to the TC very soon after substance abuse withdrawal 
are at high risk of attrition during the first few weeks of their orientation process, and 
it’s not uncommon for new residents to influence others to break the community rules 
and leave the TC with them. This negative influence of a new client can have a 
powerful effect on the dynamics of the community; so many TC programs have 
developed various procedures to decrease this risk. The allocation of a more 
experienced older client or “buddy” to help orientate and support new clients 
perceived as higher risk, and early engagement by senior staff with new clients are 
some examples of TC procedures aimed at supporting new clients through the initial 
stage after treatment entry. One participant described how it was common in New 
Zealand TCs to lessen this risk of early attrition of new clients by having an extended 
pre-admission phase for potential clients:    
 
“I was quite gob-smacked coming from New Zealand to Australia, at how (I 
mean at one level I thought it was exciting and challenging), but how different 
it was how we get residents in. Because if you listen to New Zealand people 
here, they are going to talk about their clients who arrive quite civil. But they 
are actually working with them way before they get there, so they have 
separate assessment staff that are working with them from day one, and they 
have got these visits to the TC.”  
 
“And we have prior admission to the residential treatment; they actually come 
in and have lunch at the house…. Then they get to see what the community is 
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like, and how it runs. So they might have two meals, and once they are in the 
pre-admission house, and they go over to the main house three times each 
week with all the others, so they get to see.” 
 
TC Staff 
The importance of TC staff in helping settle new clients in the therapeutic 
community was also noted, and all participants agreed with the statement below that 
client engagement was strongly influenced by early contact with clinical staff. The 
second statement below notes that this staff contact can also occur effectively in 
group format: 
 
“We found one of the predictors of retention in the early stages of treatment 
was staff contact.”   
 
“At out TC that is not necessarily that easy because we don’t actually have 
single case management with the client. So what we did was we started two 
induction groups per week for the people in the first month where they just 
came as a group and met with staff to ask questions about the TC or whatever, 
and we made sure that the personal carers or senior residents were attending 
to them all the time explaining the program. But senior staff engagement is 
predictive really of retention.”  
 
The importance of counselling staff positively engaging with new clients has 
been previously noted in the substance abuse treatment outcome and retention 
literature, (De-Weert-Van Oene, Schippers, DeJong, & Schrivers, 2001; and Barber, 
Luborsky, Gallop, Crits-Cristoph, Frank, Weiss, Thase, Connelly, Gladis, & 
Siqueland, 2001). More recently, Palmer, Murphy, Piselli, and Ball (2009) undertook 
a qualitative survey of client and outpatient treatment staff perspectives after clients 
had dropped out of treatment. The findings noted that treatment retention was 
positively affected by the development of an early therapeutic alliance between staff 
and clients. 
The number and type of professional and non-professional staff within TCs 
may vary greatly according to the size of the service, the client population, the amount 
and source of funding, the location of the TC, and the agency’s guiding philosophy of 
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substance abuse and recovery.  De Leon (2000) describes the evolution of substance 
abuse treatment from the 1960’s when almost all TC staff were persons who 
previously had substance abuse problems, commonly called recovered persons or 
persons in recovery, compared to more recent TCs that employ many professional 
staff without substance abuse histories. Modern large TCs commonly employ 
psychologists, social workers, psychotherapists, teachers, physicians, nurses, lawyers, 
accountants and other professionally trained staff, but it remains common to also 
include some recovered persons in the TC staff profile who often serve as powerful 
role models to residents.  
In substance abuse outpatient services, mental health and human services in 
the general public domain, the relationship between the client and the professional is 
viewed as the primary therapeutic element. Within the TC however, the client’s 
relationship to “the peer community” is viewed as the essential therapeutic element, 
hence the term “community as method” is often used to describe the TC treatment 
process. TC Staff serve important roles as facilitators, guides, role models, and 
managers of this client/peer community relationship.  
 Most TC programs are structured so that the client community plays a major 
role of influencing the client, however most TC and other residential services also rely 
heavily on staff counsellors. Meier, Donmall, and Heller (2004) reported the results of 
a national survey of 326 drug specialist services in England and Wales and stated that 
individual counselling was undertaken in 78% of residential services. The counselling 
provided in residential services was generally provided on a weekly basis, but only 
provided by accredited counselling staff in 62% of residential services. Staff without 
counselling certification provided individual counselling sessions in the majority of 
all drug services surveyed (74%), and in only 16% of services was counselling 
provided exclusively by qualified staff. 
Hser, Joshi, Maglione, Chou, and Anglin (2001) report the results of a survey 
of 87 programs in Los Angeles County and note that individual counselling was 
provided in 78.5% of residential programs, which is remarkably similar to the U.K. 
survey results reported above by Meier et al. (2004). Hser et al. (2001) note that the 
lower average caseload of clients (mean = 8 clients per counsellor) by residential 
counsellors was one of the few significant factors predicting client retention. 
Although the authors do not mention the percentage of residential counsellors with 
formal counselling qualifications, it can be presumed that counselling has an 
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important role in client retention due to the reported counsellor/client caseload 
retention effects. 
 Although weekly client counselling forms a major part of most residential 
treatment programs, Simpson et al. (1997) report that the effectiveness of counselling 
on retaining substance abusing clients in treatment has been demonstrated only for 
qualified and experienced counsellors. Hser et al. (2001) undertook an extensive 
analysis of retention involving 26,047 clients in 87 Los Angeles County substance 
treatment programs, and noted that staff qualifications was an important program 
factor helping predict retention in most residential programs. This researcher is not 
aware of Australian statistics regarding the proportion of counselling provision by 
graduate or post-graduate qualified staff within TC and other residential drug 
treatment services, but there is no obvious reason to suspect major differences from 
the U.K. or U.S.A. survey results reported. 
 
 
Overall Discussion 
 
It should be first noted that a relatively high proportion of the clients in this 
therapeutic community service were retained in treatment at 2 weeks and 8 weeks 
during the period of data collection. The high proportion of clients still retained at 2 
weeks especially was believed by senior clinical staff to be a consequence of the 
stringent entry criteria at this particular TC that had been designed to exclude clients 
at unacceptably high risk of early attrition and consequent program disruption. The 
TC program entry criteria required the majority of clients entering the program during 
the period of data analysis to produce at least two consecutive urinalysis samples 
showing no alcohol or illicit drug use during the one or two weeks immediately prior 
to program entry. Most pre-entry clients were engaged in outpatient counselling or 
other forms of support, and had received information about the TC program rules, 
structure and expectations. It was believed that this mandatory withdrawal, pre-entry 
support and orientation prior to TC entry greatly reduced the high rates of early 
attrition that are commonly noted in the research literature. It should therefore be 
noted that the various variables significantly predicting 8-week and 14-week client 
retention and attrition findings of this TC sample may have limited generalisability to 
other TCs with significantly different pre-admission requirements and procedures.  
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The following sections will summarise the stage one findings for each of the 
independent variables analysed in conjunction with the input from participants in the 
second stage of the study, and compare the findings with the published literature.  
 
Gender and Treatment Retention 
The finding of no significant differences between male and female retention 
rates at either 8 or 14 weeks after treatment entry was unexpected as it was not 
consistent with the literature. As previously noted this result may reflect specific 
program processes and components the TC introduced to help retain females in 
treatment. Many of the participants in the second stage of the study also mentioned 
that their TCs had introduced gender-specific program factors such as separate 
housing and gender-specific group work, and stated that they believed these program 
factors exerted important influence on both the entry and retention of female clients at 
their TC services. It is therefore probable that these gender-sensitive program factors 
that existed within the TC contributed to better access and retention of female clients. 
 Previous research has also indicated that females were more likely to enter 
substance abuse treatment with higher levels of depression and lower levels of self-
esteem, and that these women were more likely to drop out of substance abuse 
treatment prematurely (Haller, Miles, & Dawson, 2002; Wilke, 2004). The Greenfield 
et al. (2007) review note that women have often reported a higher incidence of co-
occurring mood and anxiety disorders, and therefore many women may perceive the 
lack of psychiatric services within substance abuse treatment services as a significant 
barrier to entry. It is therefore possible that the TC program studied was attractive to 
many female clients entering with high levels of depression because for the initial 
years of the data collection period it was the only Western Australian residential 
substance abuse treatment service admitting clients prescribed psychoactive 
medications for diagnosed mental health disorders. 
Previous reported findings that women are more likely to have higher levels of 
depression at treatment entry was also supported by this study where 68% of women 
compared to 48% of men entered treatment with depression levels in the clinical 
range. Several second stage participants noted that many women entered their 
programs with significantly higher need for health and mental health services than 
male clients, and believed that the provision of these services contributed to higher 
female TC access and retention rates. 
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There was no consistent major gender difference in self-esteem scores at 
treatment entry for the sample, and this contradicts the findings of many other reports 
stating that women are more likely to enter treatment with lower self-esteem. 
Women’s self-esteem scores in this sample also increased over time similar to 
increases in the men’s self-esteem scores. There was no significant gender difference 
in treatment entry anxiety scores, and these also tended to reduce for both men and 
women over time.  
 
Age and Treatment Retention 
 The stage one finding that the youngest group of clients (17-24 year olds) 
were less likely to drop out of treatment by the 14 week stage was also unexpected 
and not consistent with the majority of research regarding treatment retention. Many 
previous retention studies have reported that older clients are more easily retained in 
substance abuse treatment (Joe, Simpson, & Broome, 1998; Brecht, Greenwell, & 
Anglin, 2005). However, this finding that younger clients were more likely retained 
was accepted by many of the second stage participants who noted that their programs 
had adapted content and style in recent years to better retain the increasing number of 
young persons with alcohol and methamphetamine problems accessing their 
programs. It is therefore probable that the introduction of specific program factors to 
better retain young persons may help account for the finding. As noted previously, the 
TC program in this study had a compulsory work and training component included in 
the program structure that was believed by senior staff to have powerful positive 
psychological effects on client mood, anxiety and self-esteem, and thereby helping to 
retain younger clients. However it also remains possible that younger clients had a 
short and less severe substance use history, including less history of treatment failure, 
and were therefore less susceptible to treatment attrition.  
 
Primary Drug and Retention 
There was no significant finding for primary drug of abuse affecting retention 
which was also unexpected given most previous research has indicated programs had 
greater difficulty retaining methamphetamine-abusing clients. However the fact that 
more recent published research (Hammerbacher & Lyvers, 2006; Luchansky, 
Krupski, & Stark, 2007) has not found that methamphetamine-using clients are more 
likely to leave treatment prematurely and relapse, suggests that some treatment 
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programs may have adapted their programs to better retain these clients. Several of 
the second stage participants noted that in more recent years they experienced more 
difficulty retaining the generally older opioid-using clients in TC treatment compared 
to the commonly younger group of methamphetamine-using client group. As noted 
previously, the older clients were more likely to leave treatment before 14 weeks in 
this program. Another possible reason the methamphetamine-using clients were more 
successfully retained in treatment was the program allowed prescribed psychoactive 
medication use, especially given many methamphetamine-using clients entered the 
program with high levels of anxiety and depression. 
 
Depression, Anxiety & Self-Esteem Scores and Retention 
 An important finding of the first stage analysis was that clients with medium 
and high levels of anxiety, and high levels of depression at entry were significantly 
more likely to be retained at 8 weeks, and clients with high levels of self-esteem at 
treatment entry were significantly more likely to be retained at 14 weeks. The finding 
that high levels of anxiety and depression predicted retention was unexpected given 
the majority of previous research findings report that client mental health problems 
predict treatment attrition. This finding was accepted by most of the second stage 
participants however, several of whom noted it was common for the clients of their 
services with the most mental health problems to remain longer in treatment, 
especially when they were supported to access various health services they required. 
Although not discussed with the second stage participants, it is possible that 
the low caseloads of the relatively highly qualified counsellors in the TC program 
could account for the retention of clients with mental health difficulties. Both low 
client caseload of counsellors, and having well qualified professional counsellors have 
been noted in the literature as having a positive effect on client retention (Hser, Joshi, 
Maglione, Chou & Anglin, 2001; Simpson, Joe, Rowan-Szal, & Greener, 1997). 
Another specific program factor that may have influenced the retention of clients with 
elevated depression and anxiety scores was that the program allowed client use of 
prescribed psychoactive medications for various mental health disorders. 
 
Psychoactive Medication Use and Retention 
The stage one findings also reported that clients prescribed psychoactive 
medications were significantly more likely retained in treatment at 14 weeks. This 
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finding that pharmacotherapy may help improve client retention of clients supports 
previous research reported by Haller and Miles (2004), however very few treatment 
retention studies have reported whether clients are taking prescribed psychoactive 
medications, and this appears to be an important finding requiring further research. It 
should be noted that the use of psychoactive medications by clients within Australian 
TCs is relatively new with the majority of Australian TC treatment programs only 
allowing client medication use within the last ten to fifteen years. Although there was 
acceptance of the useful role of psychoactive medications by most of the second stage 
participants, there was a divergence in participant responses about how client 
medication use should be adopted by programs. Two participants noted that their 
programs did not allow clients to enter their services with medications because of 
concerns about the validity of mental health assessments when persons were still 
using substances prior to treatment entry. Another obstacle to client medication use 
noted by several participants was their limited reliable access to health professionals 
familiar with their programs and their understanding of substance abuse and recovery. 
Several participants described difficulties establishing enduring professional 
relationships with local medical and psychiatric services, and believed medical 
services rarely understood TC treatment processes, and tended to over-prescribe to 
substance abusing clients. These participants described extended TC pre-entry 
assessment practices they claimed allowed their staff to support new clients and more 
reliably discriminate on-going mental health problems from temporary substance–
induced mental health difficulties. The consensus view of participants however, was 
the recognition that many clients are vulnerable to attrition in the initial weeks after 
treatment admission, and various forms of support are beneficial in retaining those 
persons within the TC, whether that be various forms of peer support, psychiatric 
medication use, or extended orientation and support prior to TC entry.  
 
Limitations of This Study 
There are several limitations of this study.  These include that measures of 
various program factors, and client dynamic variables such as client motivation for 
treatment were not included in the agency’s database. Other fixed client variables 
such as years of drug use, drug use severity, previous AOD treatment, education 
levels, qualifications, and whether the client was court-mandated for treatment, were 
also not included in the database. These factors therefore could not be included in the 
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initial quantitative analysis, and it remains possible that some of these factors may be 
significant indicators of treatment attrition. Another limitation of the qualitative 
analysis is that limited resources did not enable a second coder to analyse the focus 
group data. A further limitation of this study is that the data was collected from only 
one TC and therefore findings may not be generalisable to other TC programs within 
Australia or overseas. This TC had several unusual features of operation that were 
unique within Australasian TCs at that time. These uncommon features included a 
mandatory farm work program including work skills training and the commercial 
cultivation of organic vegetables. The program was also unusual in that there was no 
incorporation of 12-step philosophy in the therapeutic program. There was an 
alternate emphasis placed on exposing clients to various recreational pursuits, the 
teaching of various stress management techniques, and instruction in mindfulness and 
other meditation practices. The program also employed at least one Masters level 
clinical psychologist on the clinical staff for most of the data collection period.  
Despite the limitations of the database utilised, and possible limitations in the 
generalisability of the findings from this study to other TCs, this study remains an 
important contribution to the Australian AOD treatment retention research literature. 
In particular, the repeat measures of mood, anxiety and self-esteem undertaken 
throughout the program, indicated that clients with significant mental health 
difficulties were able to be held in treatment without major modifications to the 
treatment program. The study also indicated that the large majority of clients reported 
significant improvement in mood scores during the initial weeks of treatment, 
irrespective of whether clients were taking prescribed psychoactive medications.  
 
Conclusion 
 The analysis of the second stage responses indicated there was general 
agreement with the first stage findings, even though the findings were obtained from a 
single Western Australian TC program, and collected from a client population from 
between six to eleven years ago. The general agreement with the first stage retention 
findings by the focus group participants may reflect that current TC client populations 
have maintained a high proportion of young persons with methamphetamine-use 
problems. The retention outcomes obtained from a decade old data sample appear to 
have remained relevant because the data were collected from the beginning of the 
rapid increase in methamphetamine-use in the Australasian region that has continued 
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to have a major influence on the profile of client treatment populations. Most of the 
second stage participants reported that the shift in dominant client population profile 
from opioid to methamphetamine use since 2000 has required major modifications of 
practices and policies within most Australian and New Zealand TCs since then. The 
retention and attrition findings of this study were not consistent with most of the 
existing literature from the U.S. and U.K. studies that have been published. However 
a major strength of this current study is that the data were collected from an 
Australian treatment population over a period of six years from within a single 
therapeutic community program. A limiting factor of the current study was that many 
client variables were not included in the data archive, and that the therapeutic 
community may have had significant differences from other TCs. Various program 
factors not included in the analyses may have influenced client attrition and retention 
rates, and therefore the findings of this study may be less generalisable to other 
residential substance abuse treatment services.  
Several second stage participants described alternate solutions that their 
Australian and New Zealand treatment programs had developed to overcome some of 
the identified client retention risk factors including the problems of retaining women, 
young persons, methamphetamine users, and persons with complex mental health 
needs. Some participants described non-medicating means of safely supporting clients 
during the early stages of TC treatment, including the early stages when mental health 
diagnoses remain uncertain and clients are experiencing major discomfort amidst 
withdrawal and change in physical and mental health symptoms. The innovative 
solutions designed for the purpose of retaining higher risk clients described by TC 
managers in the second stage of this study, may help explain why therapeutic 
communities have remained an important and enduring component of substance abuse 
treatment services within Australia and New Zealand. In support of this statement, 
Tinworth (2012) reports that the Australasian Therapeutic Community Association 
(ATCA) currently has 38 members who run 66 TCs in Australia and New Zealand.  
Although this study is an analysis of client treatment outcomes from only one 
Western Australian therapeutic community, the findings from this program combined 
with the input from other Australian and New Zealand TC managers, suggest that TCs 
remain a robust substance abuse treatment model capable of adapting their programs 
to meet complex client treatment needs, changing drug use patterns, and changing 
drug-using populations within the wider community.  
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APPENDIX A  
LETTER OF INTRODUCTION TO AGENCY DIRECTORS/CEO’S 
 
DATE 
ADDRESS 
 
 
 
Dear………, 
 
My name is Mark Porter and I am undertaking a Doctor of Psychology degree 
at Edith Cowan University. As part of my degree I am conducting a research 
study designed to assess various client factors that may contribute to client 
attrition from Alcohol and Other Drug (AOD) residential treatment services. As 
you are aware treatment attrition from AOD residential services very often 
predicts relapse to substance abuse.  
Early recognition of factors that predict client attrition may allow residential 
treatment services to instigate interventions designed to counter treatment 
attrition, and thus increase residential treatment success rates.  
 
The first stage of this research has involved an analysis of over five years of 
client data from an AOD residential treatment service designed to assess various 
client factors that may predict treatment attrition.  
 
The next stage of this research project is to discuss the research findings with 
experienced AOD residential treatment clinicians. I wish to obtain clinical 
perspectives about the findings, and where relevant discuss suggestions of 
possible interventions designed to improve retention rates with relevant client 
populations.  
 
I am seeking to involve managers and/or clinicians from several AOD 
residential treatment services and myself in a focus group that should last from 
1 to 1.5 hours. The discussion will be audio-recorded and some notes taken but 
no clinician or agency will be identified. Clinicians will have the right not to 
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answer any questions or to leave the discussion group at any time if they so 
wish. This research has been approved by the Edith Cowan University (ECU) 
Research Ethics Committee.   If you have any questions regarding the research 
then do not hesitate to call me Mark Porter on (08) 9431 3781 and, 0404 844 
227 (m), or either of my supervisors Associate Professor Lynne Cohen on 6304 
5575 or l.cohen@ecu.edu.au or Dr. David Ryder on 6304 5254 or 
david.ryder@ecu.edu.au.  If you are interested in speaking to someone 
independent of this research, please contact the University Research Ethics 
Officer, Ms. Kim Gifkins on Phone: (08) 6304 2170 or via email at: 
research.ethics@ecu.edu.au.  
 
I would appreciate your help in forwarding this letter to your Agency’s 
residential treatment service clinical staff so interested clinicians may be able to 
contact me and arrange a time and location to meet.  
 
 
Yours sincerely, 
 
 
Mark Porter       Lynne Cohen 
 
 
        
D. Psychology Candidate,       Associate 
Professor  
School of Psychology,      School of 
Psychology 
Edith Cowan University.      Edith Cowan 
University. 
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APPENDIX B 
 
LETTER OF INTRODUCTION TO TC MANAGERS & CLINICIANS 
 
 
 
 
Dear………, 
 
My name is Mark Porter and I am undertaking a Doctor of Psychology degree 
at Edith Cowan University. As part of my degree I am conducting a research 
study designed to assess various client factors that may contribute to client 
attrition from Alcohol and Other Drug (AOD) residential treatment services. As 
you are aware treatment attrition from AOD residential services very often 
predicts relapse to substance abuse. Early recognition of factors that predict 
client attrition may allow residential treatment services to instigate interventions 
designed to counter treatment attrition, and thus increase residential treatment 
success rates.  
 
The first stage of this research has involved an analysis of over six years of 
client data from an AOD residential treatment service designed to assess various 
client factors that may predict treatment attrition.  
 
The next stage of this research project is to discuss the research findings with 
experienced AOD residential treatment clinicians. I wish to obtain clinical 
perspectives about the findings, and where relevant discuss suggestions of 
possible interventions designed to improve retention rates with relevant client 
populations.  
 
I am seeking to involve clinicians from several AOD residential treatment 
services and myself in a focus group that should last from 1 to 1.5 hours. The 
discussion will be audio-recorded and some notes taken but no clinician or 
agency will be identified. Clinicians will have the right not to answer any 
questions or to leave the discussion group at any time if they so wish. This 
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research has been approved by the Edith Cowan University (ECU) Research 
Ethics Committee.  If you have any questions regarding the research then do not 
hesitate to call me Mark Porter on 0404 844 227 (mobile), or either of my 
supervisors Associate Professor Lynne Cohen on Phone: 6304 5575 or 
l.cohen@ecu.edu.au; or Dr. David Ryder on Phone: 6304 5254 or 
david.ryder@ecu.edu.au.  If you are interested in speaking to someone 
independent of this research, please contact contact the University Research 
Ethics Officer, Ms. Kim Gifkins on Phone: (08) 6304 2170 or via email at: 
research.ethics@ecu.edu.au.  
 
I appreciate your interest in being involved with this research and encourage 
you to contact me as soon as possible so I can arrange a suitable time and 
convenient location for all participants to meet.  
 
 
Yours sincerely, 
 
 
 
Mark Porter       Lynne Cohen 
 
 
        
D. Psychology Candidate,       Associate 
Professor  
School of Psychology,      School of 
Psychology 
Edith Cowan University.      Edith Cowan 
University. 
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APPENDIX C 
 
DESCRIPTION OF FOCUS GROUP FORMAT AND QUESTIONS 
 
 
INTRODUCTION: 
 
Participants will be informed that all their comments are confidential and 
should not be repeated outside of the group. Participants will be informed that 
the session will be audio-taped and notes taken to aid in later transcription of the 
session to electronic form, but reassured that all comments will not be 
identifiable.  If any identifying names are mentioned during the recording, they 
will be erased immediately.  Pseudonyms will be used and transcripts will be 
numerically coded. 
 
The focus group will begin with a brief introduction about the success of AOD 
residential treatment, but note that previous research findings have almost 
always stressed that successful long-term treatment for substance abuse is 
predicted by the amount of time in treatment. Treatment retention is therefore 
the most critical factor in determining the long-term outcome of substance abuse 
residential treatment. The research findings from the first stage of this research 
that involved an analysis of archived client data from an AOD residential 
service will be discussed with the group. 
 
DISCUSSION OF CURRENT RESEARCH FINDINGS: 
 
The group will be encouraged to express their thoughts on the research 
findings in view of their own experiences of treatment attrition of specific 
populations within their respective treatment services. 
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PROPOSED SOLUTIONS TO PROMOTE CLIENT RETENTION: 
 
The participants will be encouraged to suggest ideas that may improve 
retention generally within residential services, and specifically to identify and 
improve retention of identified populations at risk of attrition. 
 
BARRIERS TO IMPROVED RETENTION: 
 
Common ideas that emerge about how to improve treatment retention will be 
discussed, especially with respect to possible barriers to successful introduction 
in various treatment services. 
 
QUESTIONS AND DE-BRIEF: 
 
Any questions about the research will be answered and participants will be 
reminded that all responses will remain confidential, and that all notes and the 
recording of the session will be destroyed after transcription.  
 
Mark Porter       Lynne Cohen 
 
 
        
D. Psychology Candidate,       Associate 
Professor  
School of Psychology,      School of 
Psychology 
Edith Cowan University.      Edith Cowan 
University. 
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